<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for latent autoimmune diabetes (LADA) in adults - Brophy, S - 2011 | Cochrane Library</title> <meta property="og:title" content="Interventions for latent autoimmune diabetes (LADA) in adults - Brophy, S - 2011 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006165.pub3/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD006165.pub3" /> <meta name="citation_title" content="Interventions for latent autoimmune diabetes (LADA) in adults" /> <meta name="citation_author" content="Sinead Brophy" /> <meta name="citation_author_institution" content="University of Wales, Swansea" /> <meta name="citation_author_email" content="s.brophy@swansea.ac.uk" /> <meta name="citation_author" content="Helen Davies" /> <meta name="citation_author_institution" content="University of Wales, Swansea" /> <meta name="citation_author" content="Sopna Mannan" /> <meta name="citation_author_institution" content="University of Wales, Swansea" /> <meta name="citation_author" content="Huw Brunt" /> <meta name="citation_author_institution" content="National Public Health Service for Wales" /> <meta name="citation_author" content="Rhys Williams" /> <meta name="citation_author_institution" content="University of Wales, Swansea" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="9" /> <meta name="citation_doi" content="10.1002/14651858.CD006165.pub3" /> <meta name="citation_date" content="2011" /> <meta name="citation_online_date" content="2011/09/07" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006165.pub3/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006165.pub3/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006165.pub3/pdf/CDSR/CD006165/CD006165.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Autoimmune Diseases [*drug therapy, immunology]; Diabetes Mellitus, Type 2 [*drug therapy, immunology]; Drugs, Chinese Herbal [therapeutic use]; Glutamate Decarboxylase [therapeutic use]; Glycated Hemoglobin A [metabolism]; Hypoglycemic Agents [*therapeutic use]; Insulin [therapeutic use]; Metformin [therapeutic use]; Randomized Controlled Trials as Topic; Sulfonylurea Compounds [therapeutic use]; Thiazolidinediones [therapeutic use]" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1559916431000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717784000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="y8F68iId";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006165\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006165\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","ja","fr"],languageCode:"en",accessStatus:"licensed",doi:"10.1002/14651858.CD006165.pub3",title:"Interventions for latent autoimmune diabetes (LADA) in adults",firstPublishedDate:"Sep 7, 2011 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581423095000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006165.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006165.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD006165.pub3/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD006165.pub3/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006165.pub3%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD006165.PUB3" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD006165.pub3/#" data-copyright="Copyright © 2011 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <span>Read comments on this Review(0)</span> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006165.pub3/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006165.pub3/full"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-sec1-0006"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/appendices#CD006165-sec1-0012"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/table_n/CD006165StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/table_n/CD006165StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD006165.PUB3"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Interventions for latent autoimmune diabetes (LADA) in adults</h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD006165-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006165-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006165-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD006165-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">Agardh 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0001"> <div class="citation-journal">Agardh C‐D, Cilio C, Lethagen A, Lynch K, Leslie D, Palmer M, et al. <span class="citation-title">Clinical evidence for the safety of GAD65 immunomodulation in adult‐onset autoimmune diabetes</span>. <span class="citation"> Journal of diabetes and its complications </span><span class="pubYear">2005</span>;<span class="volume">19</span>:238‐46. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15993359" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+evidence+for+the+safety+of+GAD65+immunomodulation+in+adult%E2%80%90onset+autoimmune+diabetes+&author=C%E2%80%90D+Agardh&author=C+Cilio&author=A+Lethagen&author=K+Lynch&author=D+Leslie&author=M+Palmer&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">Agardh 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0002"> <div class="citation-journal">Agardh C‐D, Lynch K, Palmer M, Link K. <span class="citation-title">GAD65 vaccination: 5 years of follow‐up in a randomised dose‐escalating study in adult‐onset autoimmune diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2009</span>;<span class="volume">52</span>:1363‐68. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19404608" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=GAD65+vaccination:+5+years+of+follow%E2%80%90up+in+a+randomised+dose%E2%80%90escalating+study+in+adult%E2%80%90onset+autoimmune+diabetes+&author=C%E2%80%90D+Agardh&author=K+Lynch&author=M+Palmer&author=K+Link&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">Cabrera‐Rode 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0003"> <div class="citation-journal">Cabrera‐Rode E, Perich P, Diaz‐Horta O, Tiberti C, Molina G, Arranz C, et al. <span class="citation-title">Slowly progressing type 1 diabetes: Persistence of islet cell autoantibodies is related to glibenclamide treatment</span>. <span class="citation"> Autoimmunity </span><span class="pubYear">2002</span>;<span class="volume">35</span>(7):469‐74. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12685875" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Slowly+progressing+type+1+diabetes:+Persistence+of+islet+cell+autoantibodies+is+related+to+glibenclamide+treatment+&author=E+Cabrera%E2%80%90Rode&author=P+Perich&author=O+Diaz%E2%80%90Horta&author=C+Tiberti&author=G+Molina&author=C+Arranz&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">Davis 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0004"> <div class="citation-journal">Davis T, Wright A, Mehta Z, Cull C, Stratton I, Bottazzo G, et al. <span class="citation-title">Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control [UKPDS 70]</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2005</span>;<span class="volume">48</span>:695‐702. [MEDLINE: PMID: 15729570] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15729570" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Islet+autoantibodies+in+clinically+diagnosed+type+2+diabetes:+prevalence+and+relationship+with+metabolic+control+[UKPDS+70]+&author=T+Davis&author=A+Wright&author=Z+Mehta&author=C+Cull&author=I+Stratton&author=G+Bottazzo&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">Kobayashi 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0005"> <div class="citation-journal">Kobayashi T, Nakanishi K, Murase T, Kosaka K. <span class="citation-title">Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta cell failure in islet cell antibody positive patients with clinical features of NIDDM</span>. <span class="citation"> Diabetes </span><span class="pubYear">1996</span>;<span class="volume">45</span>:622‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8621013" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Small+doses+of+subcutaneous+insulin+as+a+strategy+for+preventing+slowly+progressive+beta+cell+failure+in+islet+cell+antibody+positive+patients+with+clinical+features+of+NIDDM+&author=T+Kobayashi&author=K+Nakanishi&author=T+Murase&author=K+Kosaka&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">L‐Hallin 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0006"> <div class="citation-journal">Landstedt‐Hallin L, Arnert P, Lins PE, Bolindert J, Olsen H, Groop L and Scandinavian insulin sulphonylurea study group research team. <span class="citation-title">The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal</span>. <span class="citation"> Diabetes Medicine </span><span class="pubYear">1999</span>;<span class="volume">16</span>:827‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+role+of+sulphonylurea+in+combination+therapy+assessed+in+a+trial+of+sulphonylurea+withdrawal+&author=L+Landstedt%E2%80%90Hallin&author=P+Arnert&author=PE+Lins&author=J+Bolindert&author=H+Olsen&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Li 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0007"> <div class="citation-journal">Li X, Liao L, Yan X, Huang G, Lin J, Lei M, Wang X, Zhou Z. <span class="citation-title">Protective effects of 1‐alpha‐hydroxyvitamin D3 on residual beta‐cell function in patients with adult‐onset latent autoimmune diabetes (LADA)</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2009</span>;<span class="volume">25</span>:411‐416. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Protective+effects+of+1%E2%80%90alpha%E2%80%90hydroxyvitamin+D3+on+residual+beta%E2%80%90cell+function+in+patients+with+adult%E2%80%90onset+latent+autoimmune+diabetes+(LADA)+&author=X+Li&author=L+Liao&author=X+Yan&author=G+Huang&author=J+Lin&author=M+Lei&author=X+Wang&author=Z+Zhou&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">Maruyama 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0008"> <div class="citation-journal">Maruyama T, Shimada A, Kanatsuka A, Kasuga A, Takei I, Yokoyama J, et al. <span class="citation-title">Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo Study)</span>. <span class="citation"> Annals of the New York Academy of Sciences </span><span class="pubYear">2003</span>;<span class="volume">1005</span>:362‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14679093" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Multicenter+prevention+trial+of+slowly+progressive+type+1+diabetes+with+small+dose+of+insulin+(the+Tokyo+Study)+&author=T+Maruyama&author=A+Shimada&author=A+Kanatsuka&author=A+Kasuga&author=I+Takei&author=J+Yokoyama&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">Maruyama 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0009"> <div class="citation-journal">Maruyama T, Tanaka S, Shimada A, Funae O, Kasuga A, Kanatsuka A, et al. <span class="citation-title">Insulin Intervention in Slowly Progressive Insulin Dependent (Type 1) Diabetes Mellitus</span>. <span class="citation"> The Journal of clinical endocrinology and metabolism </span><span class="pubYear">2008</span>;<span class="volume">93</span>(6):2115‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18397986" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+Intervention+in+Slowly+Progressive+Insulin+Dependent+(Type+1)+Diabetes+Mellitus&author=T+Maruyama&author=S+Tanaka&author=A+Shimada&author=O+Funae&author=A+Kasuga&author=A+Kanatsuka&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">Thunander 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0010"> <div class="citation-journal">Thunander M, Thorgeirsson H, Torn C, Petersson C, Landin‐Olsson M. <span class="citation-title">Beta‐cell function and metabolic control in Latent Autoimmune Diabetes in Adults (LADA) with early insulin vs conventional treatment: A three‐year follow‐up</span>. <span class="citation"> European Journal of Endocrinology </span><span class="pubYear">2011</span>;<span class="volume">164</span>:239. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21088056" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Beta%E2%80%90cell+function+and+metabolic+control+in+Latent+Autoimmune+Diabetes+in+Adults+(LADA)+with+early+insulin+vs+conventional+treatment:+A+three%E2%80%90year+follow%E2%80%90up+&author=M+Thunander&author=H+Thorgeirsson&author=C+Torn&author=C+Petersson&author=M+Landin%E2%80%90Olsson&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">Xu 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0011"> <div class="citation-journal">Xu X, Zhang D. <span class="citation-title">Effect of Tanguikang in improving the function of pancreatic islet beta cells in patients with latent autoimmune diabetes in adults</span>. <span class="citation"> Chinese Journal of Integrated Traditional and Western Medicine </span><span class="pubYear">2008</span>;<span class="volume">28</span>(10):882‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19123322" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+Tanguikang+in+improving+the+function+of+pancreatic+islet+beta+cells+in+patients+with+latent+autoimmune+diabetes+in+adults+&author=X+Xu&author=D+Zhang&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">Yang 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0012"> <div class="citation-journal">Yang Z, Zhou Z, Li X, Huang G, Lin J. <span class="citation-title">Rosiglitazone preserves islet beta‐cell function of adult onset latent autoimmune diabetes in 3 years follow‐up study</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2009</span>;<span class="volume">83</span>:54‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19008007" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+preserves+islet+beta%E2%80%90cell+function+of+adult+onset+latent+autoimmune+diabetes+in+3+years+follow%E2%80%90up+study+&author=Z+Yang&author=Z+Zhou&author=X+Li&author=G+Huang&author=J+Lin&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">Zhou 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0013"> <div class="citation-journal">Zhou Z, Li X, Huang G, Peng J, Yang L, Yan X, Wang J. <span class="citation-title">Rosiglitazone combined with insulin preserves islet beta cell function in adult‐onset latent autoimmune diabetes [LADA]</span>. <span class="citation"> Diabetes/metabolism research and reviews </span><span class="pubYear">2005</span>;<span class="volume">21</span>:203‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+combined+with+insulin+preserves+islet+beta+cell+function+in+adult%E2%80%90onset+latent+autoimmune+diabetes+[LADA]+&author=Z+Zhou&author=X+Li&author=G+Huang&author=J+Peng&author=L+Yang&author=X+Yan&author=J+Wang&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006165-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Zhu 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0014"> <div class="citation-journal">Zhu L‐Q, Liu Y‐H, Huang M. <span class="citation-title">Study on improvement of islet beta cell function in patients with latent autoimmune diabetes mellitus in adults by integrated Chinese and Western Medicine</span>. <span class="citation"> Chinese journal of integrated traditional and Western Medicien </span><span class="pubYear">2004</span>;<span class="volume">24</span>(7):581‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Study+on+improvement+of+islet+beta+cell+function+in+patients+with+latent+autoimmune+diabetes+mellitus+in+adults+by+integrated+Chinese+and+Western+Medicine+&author=L%E2%80%90Q+Zhu&author=Y%E2%80%90H+Liu&author=M+Huang&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006165-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006165-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006165-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD006165-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Alvarsson 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0015"> <div class="citation-journal">Alvarsson M, Sundkvist G, Lager I, Henricsson M, Berntorp K, Fernqvist‐Forbes E, et al. <span class="citation-title">Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetes patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(8):2231‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12882841" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Beneficial+effects+of+insulin+versus+sulphonylurea+on+insulin+secretion+and+metabolic+control+in+recently+diagnosed+type+2+diabetes+patients+&author=M+Alvarsson&author=G+Sundkvist&author=I+Lager&author=M+Henricsson&author=K+Berntorp&author=E+Fernqvist%E2%80%90Forbes&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Berkis 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0016"> <div class="citation-journal">Berkis LM, Jensen RA, Lagerquist E, Hall TR, Agardh CD, Ciliot CM, et al. <span class="citation-title">GAD65 autoantibody epitopes in adult patients with latent autoimmune diabetes following GAD65 vaccination</span>. <span class="citation"> Diabetes Medicine </span><span class="pubYear">2007</span>;<span class="volume">24</span>:521‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=GAD65+autoantibody+epitopes+in+adult+patients+with+latent+autoimmune+diabetes+following+GAD65+vaccination+&author=LM+Berkis&author=RA+Jensen&author=E+Lagerquist&author=TR+Hall&author=CD+Agardh&author=CM+Ciliot&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">Bjork 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0017"> <div class="citation-journal">Bjork E, Berne C, Kampe O, Wibell L, Oskarsson P, Karlsson F. <span class="citation-title">Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">1996</span>;<span class="volume">45</span>:1427‐30. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8826981" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diazoxide+treatment+at+onset+preserves+residual+insulin+secretion+in+adults+with+autoimmune+diabetes+&author=E+Bjork&author=C+Berne&author=O+Kampe&author=L+Wibell&author=P+Oskarsson&author=F+Karlsson&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">Chaillous 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0018"> <div class="citation-journal">Chaillous L, Lefevre H, Thivolet C, Boitard C, Lahlou N, Atlan‐Gepner C, et al. <span class="citation-title">Oral insulin administration and residual Beta cell function in recent onset type 1 diabetes: a Multicentre randomised controlled trial</span>. <span class="citation"> The Lancet </span><span class="pubYear">2000</span>;<span class="volume">356</span>:545‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Oral+insulin+administration+and+residual+Beta+cell+function+in+recent+onset+type+1+diabetes:+a+Multicentre+randomised+controlled+trial+&author=L+Chaillous&author=H+Lefevre&author=C+Thivolet&author=C+Boitard&author=N+Lahlou&author=C+Atlan%E2%80%90Gepner&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">Conget 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0019"> <div class="citation-journal">Conget I, Aguilera E, Pellitero S, Naf S, Bendtzen K, Casamitjana R, et al. <span class="citation-title">Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2005</span>;<span class="volume">48</span>:1464‐8. [MEDLINE: PMID: 15995847] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15995847" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lack+of+effect+of+intermittently+administered+sodium+fusidate+in+patients+with+newly+diagnosed+type+1+diabetes+mellitus:+the+FUSIDM+trial+&author=I+Conget&author=E+Aguilera&author=S+Pellitero&author=S+Naf&author=K+Bendtzen&author=R+Casamitjana&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">DCCT Group 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0020"> <div class="citation-journal">DCCT Research Group. <span class="citation-title">Effect of intensive therapy on residual beta cell function in patients with type 1 diabetes in the diabetes control and complications trial</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1998</span>;<span class="volume">128</span>(7):517‐23. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9518395" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Desai 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0021"> <div class="citation-journal">Desai M, Cull CA, Horton VA, Christie MR, Bonifacio E, Lampasona, V, et al. <span class="citation-title">GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2007</span>;<span class="volume">50</span>:2052‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17657474" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=GAD+autoantibodies+and+epitope+reactivities+persist+after+diagnosis+in+latent+autoimmune+diabetes+in+adults+but+do+not+predict+disease+progression:+UKPDS+77+&author=M+Desai&author=CA+Cull&author=VA+Horton&author=MR+Christie&author=E+Bonifacio&author=+Lampasona&author=+V&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Desai 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0022"> <div class="citation-journal">Desai M, Clark A. <span class="citation-title">Autoimmune diabetes in adults: lessons from the UKPDS</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2008</span>;<span class="volume">25 (Suppl 2)</span>:30‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18717976" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Autoimmune+diabetes+in+adults:+lessons+from+the+UKPDS&author=M+Desai&author=A+Clark&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">E‐Longmire 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0023"> <div class="citation-journal">Ergun‐Longmire B, Marker J, Zeidler A, Rapaport R, Raskin P, Bode B, et al. <span class="citation-title">Oral insulin therapy to prevent progression of immune‐mediated (type 1) diabetes</span>. <span class="citation"> Annals of the New York Academy of Sciences </span><span class="pubYear">2004</span>;<span class="volume">1029</span>:260‐77. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15681764" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Oral+insulin+therapy+to+prevent+progression+of+immune%E2%80%90mediated+(type+1)+diabetes&author=B+Ergun%E2%80%90Longmire&author=J+Marker&author=A+Zeidler&author=R+Rapaport&author=P+Raskin&author=B+Bode&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">Goday 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0024"> <div class="citation-journal">Goday A, Pujol‐Borrell R, Fernadez J, Casamitjana R, Rios M, Vilardell E, Gomis R. <span class="citation-title">Effects of a short prednisone regime at clinical onset of type 1 diabetes</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1993</span>;<span class="volume">20</span>:39‐46. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8344127" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+a+short+prednisone+regime+at+clinical+onset+of+type+1+diabetes&author=A+Goday&author=R+Pujol%E2%80%90Borrell&author=J+Fernadez&author=R+Casamitjana&author=M+Rios&author=E+Vilardell&author=R+Gomis&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">Heise 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0025"> <div class="citation-journal">Heise T, Bott S, Tusek C, Stephan J‐A, Kawabata T, Finco‐Kent D, et al. <span class="citation-title">The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:2161‐9. [MEDLINE: PMID: 16123484] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16123484" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+insulin+antibodies+on+the+metabolic+action+of+inhaled+and+subcutaneous+insulin+&author=T+Heise&author=S+Bott&author=C+Tusek&author=J%E2%80%90A+Stephan&author=T+Kawabata&author=D+Finco%E2%80%90Kent&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Karges 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0026"> <div class="citation-journal">Karges B, Durinovic‐Bello, Heinze E, Boehm B, Debatin K‐M, Karges W. <span class="citation-title">Complete long term recovery of beta cell function in autoimmune type 1 diabetes after insulin treatment</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>(5):1207‐8. [MEDLINE: PMID: 15111548] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15111548" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Complete+long+term+recovery+of+beta+cell+function+in+autoimmune+type+1+diabetes+after+insulin+treatment+&author=B+Karges&author=+Durinovic%E2%80%90Bello&author=E+Heinze&author=B+Boehm&author=K%E2%80%90M+Debatin&author=W+Karges&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">Kobayashi 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0027"> <div class="citation-journal">Kobayashi T, Maruyama T, Shimada A, Kasuga A, Kanatsuka A, Takei I, et al. <span class="citation-title">Insulin intervention to preserve beta cells in slowly progressive insulin dependent (type 1) diabetes mellitus</span>. <span class="citation"> Annals of the New York Academy of Sciences </span><span class="pubYear">2002</span>;<span class="volume">958</span>:117‐30. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12021091" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+intervention+to+preserve+beta+cells+in+slowly+progressive+insulin+dependent+(type+1)+diabetes+mellitus+&author=T+Kobayashi&author=T+Maruyama&author=A+Shimada&author=A+Kasuga&author=A+Kanatsuka&author=I+Takei&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">Leslie 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0028"> <div class="citation-journal">Leslie R. <span class="citation-title">Intervention in patients with type 1 diabetes masquerading as type II diabetes</span>. <span class="citation"> Diabetes Nutrition Metabolism </span><span class="pubYear">1996</span>;<span class="volume">9</span>:319‐24. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intervention+in+patients+with+type+1+diabetes+masquerading+as+type+II+diabetes&author=R+Leslie&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">Leslie 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0029"> <div class="citation-journal">Leslie RDG, Kolb H, Schloot NC, Buzzetti R, Mauricio D, Leiva A, et al. <span class="citation-title">Diabetes classification:grey zones, sound and smoke: Action LADA1</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2008</span>;<span class="volume">24</span>:511‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetes+classification:grey+zones,+sound+and+smoke:+Action+LADA1&author=RDG+Leslie&author=H+Kolb&author=NC+Schloot&author=R+Buzzetti&author=D+Mauricio&author=A+Leiva&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">Linn 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0030"> <div class="citation-journal">Linn T, Ortac K, Laube H, Federlin K. <span class="citation-title">Intensive therapy in adult insulin dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomised, controlled prospective study over 5 years in newly diagnosed patients</span>. <span class="citation"> Metabolism </span><span class="pubYear">1996</span>;<span class="volume">45</span>(12):1508‐13. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8969284" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+therapy+in+adult+insulin+dependent+diabetes+mellitus+is+associated+with+improved+insulin+sensitivity+and+reserve:+a+randomised,+controlled+prospective+study+over+5+years+in+newly+diagnosed+patients+&author=T+Linn&author=K+Ortac&author=H+Laube&author=K+Federlin&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">Littorin 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0031"> <div class="citation-journal">Littorin B, Sundkvist G, Hagopian W, Landin‐Olsson M, Lernmark A, Ostman J, et al. <span class="citation-title">Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(3):409‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10097919" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Islet+cell+and+glutamic+acid+decarboxylase+antibodies+present+at+diagnosis+of+diabetes+predict+the+need+for+insulin+treatment+&author=B+Littorin&author=G+Sundkvist&author=W+Hagopian&author=M+Landin%E2%80%90Olsson&author=A+Lernmark&author=J+Ostman&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">Loriz Peralta 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0032"> <div class="citation-journal">Loriz Peralta O, Campos Bonilla B, Granda Ybern ML, Sanmarti Sala A, Arroyo Bros J. <span class="citation-title">Detection of LADA‐type diabetes in overweight diabetic patients. Is treatment with metformin suitable?</span>. <span class="citation"> Aten Primaria </span><span class="pubYear">2007</span>;<span class="volume">39</span>(3):133‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17386205" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Detection+of+LADA%E2%80%90type+diabetes+in+overweight+diabetic+patients.+Is+treatment+with+metformin+suitable?+&author=O+LorizPeralta&author=B+CamposBonilla&author=ML+GrandaYbern&author=A+SanmartiSala&author=J+ArroyoBros&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Martin 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0033"> <div class="citation-journal">Martin S, Schernthaner G, Nerup J, Gries F, Koivisto V, Dupre J, et al. <span class="citation-title">Follow‐up of cyclosporin A, treatment in type 1 (insulin ‐ dependent) diabetes mellitus: lack of long term effects</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1991</span>;<span class="volume">34</span>:429‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1884902" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Follow%E2%80%90up+of+cyclosporin+A,+treatment+in+type+1+(insulin+%E2%80%90+dependent)+diabetes+mellitus:+lack+of+long+term+effects+&author=S+Martin&author=G+Schernthaner&author=J+Nerup&author=F+Gries&author=V+Koivisto&author=J+Dupre&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Matsumoto 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0034"> <div class="citation-journal">Matsumoto M, Satou S. <span class="citation-title">Small doses of insulin may prevent the decrease of intrinsic insulin secretion in anti‐GAD, ICA and IA‐2 antibody‐positive slowly progressive type 1 diabetes</span>. <span class="citation"> Journal of the Japan Diabetes Society </span><span class="pubYear">2005</span>;<span class="volume">48</span>(4):257‐61. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Small+doses+of+insulin+may+prevent+the+decrease+of+intrinsic+insulin+secretion+in+anti%E2%80%90GAD,+ICA+and+IA%E2%80%902+antibody%E2%80%90positive+slowly+progressive+type+1+diabetes+&author=M+Matsumoto&author=S+Satou&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Mattews 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0035"> <div class="citation-journal">Matthews D, Cull C, Stratton I, Holman R, Turner R. <span class="citation-title">UKPDS 26: Sulphonylurea failure in non‐insulin dependent diabetic patients over six years</span>. <span class="citation"> Diabetic medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>:297‐303. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9585394" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=UKPDS+26:+Sulphonylurea+failure+in+non%E2%80%90insulin+dependent+diabetic+patients+over+six+years+&author=D+Matthews&author=C+Cull&author=I+Stratton&author=R+Holman&author=R+Turner&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">Mayorov A 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0036"> <div class="citation-journal">Mayorov A, Naumenkova I, Antsiferov M, Dedov I. <span class="citation-title">Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2005</span>;<span class="volume">68</span>:S54‐S59. [MEDLINE: PMID: 15955377] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15955377" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Influence+of+insulin+treatment+on+insulin+sensitivity+in+insulin+requiring+type+2+diabetes+patients+&author=A+Mayorov&author=I+Naumenkova&author=M+Antsiferov&author=I+Dedov&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">Murao 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0037"> <div class="citation-journal">Murao S, Kondo S, Ohashi J, Fujii Y, Shimizu I, Fujiyama M, et al. <span class="citation-title">Anti‐thyroid peroxidase antibody, IA‐2 antibody and fasting C‐peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA). A 5 year follow‐up of the Ehime study</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2008</span>;<span class="volume">80</span>:114‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18342387" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Anti%E2%80%90thyroid+peroxidase+antibody,+IA%E2%80%902+antibody+and+fasting+C%E2%80%90peptide+levels+predict+beta+cell+failure+in+patients+with+latent+autoimmune+diabetes+in+adults+(LADA).+A+5+year+follow%E2%80%90up+of+the+Ehime+study+&author=S+Murao&author=S+Kondo&author=J+Ohashi&author=Y+Fujii&author=I+Shimizu&author=M+Fujiyama&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Ovalle 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0038"> <div class="citation-journal">Ovalle F, Bell D. <span class="citation-title">Effect of Rosiglitazone versus insulin on the pancreatic beta cell function of subjects with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>(11):2585‐9. [MEDLINE: PMID: 15504990] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15504990" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+Rosiglitazone+versus+insulin+on+the+pancreatic+beta+cell+function+of+subjects+with+type+2+diabetes+&author=F+Ovalle&author=D+Bell&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Pozzilli 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0039"> <div class="citation-journal">Pozzilli P, Visalli N, Cavallo M, Signore A, Baroni M, Buzzetti R et al and the IMDIAB study Group. <span class="citation-title">Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin dependent diabetes (the IMDIAB IV study)</span>. <span class="citation"> European Journal of Endocrinology </span><span class="pubYear">1997</span>;<span class="volume">137</span>:234‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9330586" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Vitamin+E+and+nicotinamide+have+similar+effects+in+maintaining+residual+beta+cell+function+in+recent+onset+insulin+dependent+diabetes+(the+IMDIAB+IV+study)+&author=P+Pozzilli&author=N+Visalli&author=M+Cavallo&author=A+Signore&author=M+Baroni&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Pozzilli 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0040"> <div class="citation-journal">Pozzilli P, Pitocco D, Visalli N, Cavallo G, Buzzetti R, Crino A, et al. <span class="citation-title">No effect of oral insulin on residual beta‐cell function in recent‐onset type 1 diabetes (the IMDIAB VII)</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2000</span>;<span class="volume">43</span>:1000‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10990077" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=No+effect+of+oral+insulin+on+residual+beta%E2%80%90cell+function+in+recent%E2%80%90onset+type+1+diabetes+(the+IMDIAB+VII)+&author=P+Pozzilli&author=D+Pitocco&author=N+Visalli&author=G+Cavallo&author=R+Buzzetti&author=A+Crino&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">Pugliese 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0041"> <div class="citation-journal">Pugliese A. <span class="citation-title">Peptide‐based treatment for autoimmune diseases: learning how to handle a double‐edged sword</span>. <span class="citation"> Journal of Clinical Investigation </span><span class="pubYear">2003</span>;<span class="volume">111</span>:1280‐2. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12727917" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Peptide%E2%80%90based+treatment+for+autoimmune+diseases:+learning+how+to+handle+a+double%E2%80%90edged+sword+&author=A+Pugliese&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Ravnik‐Oblak 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0042"> <div class="citation-journal">Ravnik‐Oblak M, Mrevlje F. <span class="citation-title">Insulin versus a combination of insulin and sulphonylurea in the treatment of NIDDM patients with secondary oral failure</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1995</span>;<span class="volume">30</span>:27‐35. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8745203" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+versus+a+combination+of+insulin+and+sulphonylurea+in+the+treatment+of+NIDDM+patients+with+secondary+oral+failure+&author=M+Ravnik%E2%80%90Oblak&author=F+Mrevlje&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">Raz 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0043"> <div class="citation-journal">Raz I, Avron A, Tamir M, Metzger M, Symer L, Eldor R, et al. <span class="citation-title">Treatment of new‐onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta‐cell function: extension of a randomised, double‐blind, phase II trial</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2007</span>;<span class="volume">23</span>:292‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+of+new%E2%80%90onset+type+1+diabetes+with+peptide+DiaPep277+is+safe+and+associated+with+preserved+beta%E2%80%90cell+function:+extension+of+a+randomised,+double%E2%80%90blind,+phase+II+trial+&author=I+Raz&author=A+Avron&author=M+Tamir&author=M+Metzger&author=L+Symer&author=R+Eldor&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">Rosario 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0044"> <div class="citation-journal">Rosario PWS, Reis JS, Fagundes TA, Calsolari MR, Amim R, Silva SC, et al. <span class="citation-title">Latent Autoimmune Diabetes in Adults (LADA): Usefulness of Anti‐Gad Antibody Titers and Benefit of Early Insulinization</span>. <span class="citation"> Arquivos Brasileiros de Endocrinologia e Metabologia </span><span class="pubYear">2007</span>;<span class="volume">51/1</span>:52‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Latent+Autoimmune+Diabetes+in+Adults+(LADA):+Usefulness+of+Anti%E2%80%90Gad+Antibody+Titers+and+Benefit+of+Early+Insulinization+&author=PWS+Rosario&author=JS+Reis&author=TA+Fagundes&author=MR+Calsolari&author=R+Amim&author=SC+Silva&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Sa 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0045"> <div class="citation-journal">Sa J, Silva R, Nasri F, Velloso L, Chacra A, Dib S. <span class="citation-title">Non‐obese adult onset diabetes with oral hypoglycaemic agent failure: islet cell autoantibodies or reversible beta cell refractoriness?</span>. <span class="citation"> Brazillian Journal of Medical and Biological Research </span><span class="pubYear">2003</span>;<span class="volume">36</span>:1301‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Non%E2%80%90obese+adult+onset+diabetes+with+oral+hypoglycaemic+agent+failure:+islet+cell+autoantibodies+or+reversible+beta+cell+refractoriness?+&author=J+Sa&author=R+Silva&author=F+Nasri&author=L+Velloso&author=A+Chacra&author=S+Dib&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">Schloot 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0046"> <div class="citation-journal">Schloot NC, Meierhoff G, Lengyel C, Vandorfi G, Takacs J, Panczel P, et al. <span class="citation-title">Effect of heat shock protein peptide DiaPep277 on Beta‐cell function in paediatric and adult patients with recent‐onset diabetes mellitus type 1: two prospective, randomised, double‐blind phase II trials</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2007</span>;<span class="volume">23</span>:276‐85. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+heat+shock+protein+peptide+DiaPep277+on+Beta%E2%80%90cell+function+in+paediatric+and+adult+patients+with+recent%E2%80%90onset+diabetes+mellitus+type+1:+two+prospective,+randomised,+double%E2%80%90blind+phase+II+trials+&author=NC+Schloot&author=G+Meierhoff&author=C+Lengyel&author=G+Vandorfi&author=J+Takacs&author=P+Panczel&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">Schories 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0047"> <div class="citation-journal">Schories M, Peters T, Rasenack J, Reincke M. <span class="citation-title">Islet‐cell antibodies and type 1 diabetes after treatment with interferon‐alpha</span>. <span class="citation"> Deutsche Medizinische Wochenschrift </span><span class="pubYear">2004</span>;<span class="volume">129</span>:1120‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15143453" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Islet%E2%80%90cell+antibodies+and+type+1+diabetes+after+treatment+with+interferon%E2%80%90alpha&author=M+Schories&author=T+Peters&author=J+Rasenack&author=M+Reincke&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">Scranton 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0048"> <div class="citation-other">Scranton R, Su M, Turner R, Testa M. <span class="citation-title">Quality of life considerations for insulin versus oral agent therapy in persons presenting with characteristics of latent autoimmune diabetes in adults [LADA]</span>. American Diabetes Association. <span class="pubYear">2004</span>:Abstract number: 1835‐P. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Quality+of+life+considerations+for+insulin+versus+oral+agent+therapy+in+persons+presenting+with+characteristics+of+latent+autoimmune+diabetes+in+adults+[LADA]+&author=R+Scranton&author=M+Su&author=R+Turner&author=M+Testa&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Secchi 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0049"> <div class="citation-journal">Secchi A, Pastore M, Sergi A, Pontiroli A, Pozza G. <span class="citation-title">Prednisone administration in recent onset type 1 diabetes</span>. <span class="citation"> Journal of autoimmunity </span><span class="pubYear">1990</span>;<span class="volume">3</span>:593‐600. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2252527" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prednisone+administration+in+recent+onset+type+1+diabetes&author=A+Secchi&author=M+Pastore&author=A+Sergi&author=A+Pontiroli&author=G+Pozza&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Steffes 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0050"> <div class="citation-journal">Steffes M, Jackson M, Sibley S, Thomas W. <span class="citation-title">Beta cell Function and the development of diabetes related complications in the diabetes control and complications trial</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(3):832‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12610045" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Beta+cell+Function+and+the+development+of+diabetes+related+complications+in+the+diabetes+control+and+complications+trial+&author=M+Steffes&author=M+Jackson&author=S+Sibley&author=W+Thomas&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Stenstrom 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0051"> <div class="citation-journal">Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G. <span class="citation-title">Latent autoimmune diabetes in adults: Definition, prevalence, Beta cell function and treatment</span>. <span class="citation"> Diabetes </span><span class="pubYear">2005</span>;<span class="volume">54</span>(S2):S68‐S72. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16306343" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Latent+autoimmune+diabetes+in+adults:+Definition,+prevalence,+Beta+cell+function+and+treatment+&author=G+Stenstrom&author=A+Gottsater&author=E+Bakhtadze&author=B+Berger&author=G+Sundkvist&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">Takino 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0052"> <div class="citation-journal">Takino H, Yamasaki H, Sera Y, Abe T, Ozaki M, Kondo H, et al. <span class="citation-title">The preliminary report from the nation‐wide prevention study for type 1 diabetes initially diagnosed as type 2 in Japan</span>. <span class="citation"> Diabetes/metabolism reviews </span><span class="pubYear">1998</span>;<span class="volume">14</span>:329‐35. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+preliminary+report+from+the+nation%E2%80%90wide+prevention+study+for+type+1+diabetes+initially+diagnosed+as+type+2+in+Japan+&author=H+Takino&author=H+Yamasaki&author=Y+Sera&author=T+Abe&author=M+Ozaki&author=H+Kondo&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">Turner 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0053"> <div class="citation-journal">Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay I, et al. <span class="citation-title">UKPDS 25: autoantibodies in islet‐cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes</span>. <span class="citation"> The Lancet </span><span class="pubYear">1997</span>;<span class="volume">350</span>:1288‐93. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=UKPDS+25:+autoantibodies+in+islet%E2%80%90cell+cytoplasm+and+glutamic+acid+decarboxylase+for+prediction+of+insulin+requirement+in+type+2+diabetes+&author=R+Turner&author=I+Stratton&author=V+Horton&author=S+Manley&author=P+Zimmet&author=I+Mackay&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">van Deutekom 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0054"> <div class="citation-journal">Deutekom AW, Heine RJ, Simsek S. <span class="citation-title">The islet autoantibody titre: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2007</span>;<span class="volume">25</span>:117‐25. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18028440" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+islet+autoantibody+titre:+their+clinical+relevance+in+latent+autoimmune+diabetes+in+adults+(LADA)+and+the+classification+of+diabetes+mellitus+&author=AW+Deutekom&author=RJ+Heine&author=S+Simsek&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">Vidal 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0055"> <div class="citation-journal">Vidal J, Fernandez‐Balsells M, Sesmilo G, Aguilera E, Casamitjana R, Gomis R, et al. <span class="citation-title">Effects of Nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(3):360‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10868866" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+Nicotinamide+and+intravenous+insulin+therapy+in+newly+diagnosed+type+1+diabetes+&author=J+Vidal&author=M+Fernandez%E2%80%90Balsells&author=G+Sesmilo&author=E+Aguilera&author=R+Casamitjana&author=R+Gomis&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0056"> <div class="reference-title-banner"> <h4 class="title">Weng 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0056"> <div class="citation-journal">Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, et al. <span class="citation-title">Effect of intensive insulin therapy on Beta‐cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a Multicentre randomised parallel‐group trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">May 24</span>:1753‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+intensive+insulin+therapy+on+Beta%E2%80%90cell+function+and+glycaemic+control+in+patients+with+newly+diagnosed+type+2+diabetes:+a+Multicentre+randomised+parallel%E2%80%90group+trial+&author=J+Weng&author=Y+Li&author=W+Xu&author=L+Shi&author=Q+Zhang&author=D+Zhu&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006165-bbs2-0057"> <div class="reference-title-banner"> <h4 class="title">Zinman 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0057"> <div class="citation-journal">Zinman B, Kahn SE, Haffner SM, O'Neill MC, Heise MA, Freed MI, ADOPT Study Group. <span class="citation-title">Phenotypic Characteristics of GAD antibody positive recently diagnosed patients with type 2 diabetes in north America and Europe</span>. <span class="citation"> Diabetes </span><span class="pubYear">2004</span>;<span class="volume">53</span>:3193‐200. [MEDLINE: PMID: 15561950] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15561950" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Phenotypic+Characteristics+of+GAD+antibody+positive+recently+diagnosed+patients+with+type+2+diabetes+in+north+America+and+Europe+&author=B+Zinman&author=SE+Kahn&author=SM+Haffner&author=MC+O'Neill&author=MA+Heise&author=MI+Freed&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006165-bbs1-0003"> <h3 class="title">References to ongoing studies</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006165-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006165-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006165-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006165-bbs2-0058"> <div class="reference-title-banner"> <h4 class="title">Agardh 2004 {unpublished data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0058"> <div class="citation-other"><span class="citation-title">Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult)</span>. Ongoing study<span class="pubYear">December 2004</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006165-bbs2-0059"> <div class="reference-title-banner"> <h4 class="title">Brophy 2007 {unpublished data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0059"> <div class="citation-other"><span class="citation-title">Randomised, controlled, parallel‐group study to investigate the clinical effectiveness of early insulin treatment in patients with LADA</span>. Ongoing study<span class="pubYear">2007</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006165-bbs2-0060"> <div class="reference-title-banner"> <h4 class="title">Buzzetti 2006 {unpublished data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0060"> <div class="citation-other"><span class="citation-title">Non Insulin Requiring Autoimmune Diabetes (NIRAD) project</span>. Ongoing study<span class="pubYear">2006</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006165-bbs2-0061"> <div class="reference-title-banner"> <h4 class="title">Grill 2010 {unpublished data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0061"> <div class="citation-other"><span class="citation-title">Is &quot;Beta Cell Rest&quot; by Insulin Treatment Beneficial Compared to State‐of‐the Art Enhancers of Insulin Secretion in Preserving Beta Cell Function in Subjects With Latent Autoimmune Diabetes of the Adult (LADA)?</span>. Ongoing study<span class="pubYear">March 2009</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006165-bbs2-0062"> <div class="reference-title-banner"> <h4 class="title">Palmer 2000 {unpublished data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0062"> <div class="citation-other"><span class="citation-title">Rosiglitazone intervention study on patients with type 1.5 diabetes</span>. Ongoing study<span class="pubYear">2000</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006165-bbs2-0063"> <div class="reference-title-banner"> <h4 class="title">Palmer 2009 {unpublished data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0063"> <div class="citation-other"><span class="citation-title">Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)</span>. Ongoing study<span class="pubYear">October 2002</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006165-bbs2-0064"> <div class="reference-title-banner"> <h4 class="title">Zhou 2010 {unpublished data only} </h4> </div> <div class="bibliography-section" id="CD006165-bib-0064"> <div class="citation-other"><span class="citation-title">Protective Effects of Sitagliptin on β Cell Function in Patients With Adult‐onset Latent Autoimmune Diabetes(LADA) (DPP‐ⅣLADA)</span>. Ongoing study<span class="pubYear">May 2010</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006165-bbs1-0004"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006165-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006165-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006165-bbs1-0003">ongoing studies</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0065"> <div class="reference-title-banner"> <h4 class="title">Amori 2007</h4> </div> <div class="bibliography-section" id="CD006165-bib-0065"> <div class="citation-journal">Amori RE, Lau J, Pittas AG. <span class="citation-title">Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta‐analysis</span>. <span class="citation"> JAMA </span><span class="pubYear">2007</span>;<span class="volume">298</span>(2):194‐206. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17622601" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+incretin+therapy+in+type+2+diabetes:+systematic+review+and+meta%E2%80%90analysis+&author=RE+Amori&author=J+Lau&author=AG+Pittas&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0066"> <div class="reference-title-banner"> <h4 class="title">Appel 2009</h4> </div> <div class="bibliography-section" id="CD006165-bib-0066"> <div class="citation-journal">Appel SJ, Wadas TM, Rosenthal RS, Ovalle F. <span class="citation-title">Latent autoimmune diabetes of adulthood (LADA): an often misdiagnosed type of diabetes mellitus</span>. <span class="citation"> Journal of the American Academy of Nurse Practitioners </span><span class="pubYear">2009</span>;<span class="volume">21</span>(3):156‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19302691" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Latent+autoimmune+diabetes+of+adulthood+(LADA):+an+often+misdiagnosed+type+of+diabetes+mellitus+&author=SJ+Appel&author=TM+Wadas&author=RS+Rosenthal&author=F+Ovalle&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0067"> <div class="reference-title-banner"> <h4 class="title">Beales 2002</h4> </div> <div class="bibliography-section" id="CD006165-bib-0067"> <div class="citation-journal">Beales P, Pozzilli P. <span class="citation-title">Thiazolidinediones for the prevention of diabetes in the non‐obese diabetic (NOD) mouse: implications for human type 1 diabetes</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2002</span>;<span class="volume">18</span>(2):114‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Thiazolidinediones+for+the+prevention+of+diabetes+in+the+non%E2%80%90obese+diabetic+(NOD)+mouse:+implications+for+human+type+1+diabetes+&author=P+Beales&author=P+Pozzilli&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0068"> <div class="reference-title-banner"> <h4 class="title">Bingley 2003</h4> </div> <div class="bibliography-section" id="CD006165-bib-0068"> <div class="citation-journal">Bingley P, Bonifacio E, Mueller P. <span class="citation-title">Diabetes Antibody Standardization Program, first assay proficiency evaluation</span>. <span class="citation"> Diabetes </span><span class="pubYear">2003</span>;<span class="volume">52</span>(5):1128‐36. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12716742" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetes+Antibody+Standardization+Program,+first+assay+proficiency+evaluation&author=P+Bingley&author=E+Bonifacio&author=P+Mueller&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0069"> <div class="reference-title-banner"> <h4 class="title">Black 2003</h4> </div> <div class="bibliography-section" id="CD006165-bib-0069"> <div class="citation-journal">Black C, McIntyre L, Mesa‐Perez JA, Royle PL, Thomas S, Waugh N. <span class="citation-title">Meglitinide analogues for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2003</span>, Issue 4. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD004654.pub2" target="_blank"><span>10.1002/14651858.CD004654.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Meglitinide+analogues+for+type+2+diabetes+mellitus&author=C+Black&author=L+McIntyre&author=JA+Mesa%E2%80%90Perez&author=PL+Royle&author=S+Thomas&author=N+Waugh&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0070"> <div class="reference-title-banner"> <h4 class="title">Brophy 2006</h4> </div> <div class="bibliography-section" id="CD006165-bib-0070"> <div class="citation-other">Brophy S, Williams D.R.R, Leslie D on behalf of the Action LADA Research Group. <span class="citation-title">Epidemiology of latent autoimmune diabetes [LADA] in eight centres in Europe</span>. Diabetic medicine. <span class="pubYear">2006</span>; Vol. 23:4 Suppl. [ISSN 0742‐3071] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Epidemiology+of+latent+autoimmune+diabetes+[LADA]+in+eight+centres+in+Europe&author=S+Brophy&author=D.R.R+Williams&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0071"> <div class="reference-title-banner"> <h4 class="title">Brophy 2011</h4> </div> <div class="bibliography-section" id="CD006165-bib-0071"> <div class="citation-journal">Brophy S, Davies H, Dunseath G, Stephens JW, Platts J, Lane H, et al. <span class="citation-title">Experience of the introduction of routine antibody testing in primary care and of running a trial for latent autoimmune diabetes in adults (LADA)</span>. <span class="citation"> Diabetes research and clinical practice </span><span class="pubYear">2011</span>;<span class="volume">Epub ahead of print</span>((Apr 2011)). <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Experience+of+the+introduction+of+routine+antibody+testing+in+primary+care+and+of+running+a+trial+for+latent+autoimmune+diabetes+in+adults+(LADA)+&author=S+Brophy&author=H+Davies&author=G+Dunseath&author=JW+Stephens&author=J+Platts&author=H+Lane&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0072"> <div class="reference-title-banner"> <h4 class="title">Cabrera‐Rode 2002</h4> </div> <div class="bibliography-section" id="CD006165-bib-0072"> <div class="citation-journal">Cabrera‐Rode E, Perich P, Diaz‐Horta O, Tiberti C, Molina G, Arranz D, et al. <span class="citation-title">Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment</span>. <span class="citation"> Autoimmunity </span><span class="pubYear">2002</span>;<span class="volume">35</span>(7):469‐74. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12685875" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Slowly+progressing+type+1+diabetes:+persistence+of+islet+cell+autoantibodies+is+related+to+glibenclamide+treatment+&author=E+Cabrera%E2%80%90Rode&author=P+Perich&author=O+Diaz%E2%80%90Horta&author=C+Tiberti&author=G+Molina&author=D+Arranz&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0073"> <div class="reference-title-banner"> <h4 class="title">Cohen 1960</h4> </div> <div class="bibliography-section" id="CD006165-bib-0073"> <div class="citation-journal">Cohen J. <span class="citation-title">A coefficient of agreement for nominal scales</span>. <span class="citation"> Educational and Psychological Measurement </span><span class="pubYear">1960</span>;<span class="volume">20</span>:37‐46. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+coefficient+of+agreement+for+nominal+scales&author=J+Cohen&publication_year=1960&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0074"> <div class="reference-title-banner"> <h4 class="title">Davies 2008</h4> </div> <div class="bibliography-section" id="CD006165-bib-0074"> <div class="citation-journal">Davies H, Brophy S, Fielding A, Bingley P, Chandler M, Hilldrup I, et al. <span class="citation-title">Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2008</span>;<span class="volume">25</span>:1354‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19046228" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Latent+autoimmune+diabetes+in+adults+(LADA)+in+South+Wales:+incidence+and+characterization&author=H+Davies&author=S+Brophy&author=A+Fielding&author=P+Bingley&author=M+Chandler&author=I+Hilldrup&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0075"> <div class="reference-title-banner"> <h4 class="title">Gale 2005</h4> </div> <div class="bibliography-section" id="CD006165-bib-0075"> <div class="citation-journal">Gale E. <span class="citation-title">Latent autoimmune diabetes in adults: a guide for the perplexed</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2005</span>;<span class="volume">48</span>:2195‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16193287" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Latent+autoimmune+diabetes+in+adults:+a+guide+for+the+perplexed&author=E+Gale&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0076"> <div class="reference-title-banner"> <h4 class="title">Higgins 2002</h4> </div> <div class="bibliography-section" id="CD006165-bib-0076"> <div class="citation-journal">Higgins JPT, Thompson SG. <span class="citation-title">Quantifying heterogeneity in a meta‐analysis</span>. <span class="citation"> Statistics in medicine </span><span class="pubYear">2002</span>;<span class="volume">21</span>:1539‐58. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12111919" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Quantifying+heterogeneity+in+a+meta%E2%80%90analysis&author=JPT+Higgins&author=SG+Thompson&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0077"> <div class="reference-title-banner"> <h4 class="title">Higgins 2003</h4> </div> <div class="bibliography-section" id="CD006165-bib-0077"> <div class="citation-journal">Higgins JP, Thompson SG, Deeks JJ, Altman DG. <span class="citation-title">Measuring inconsistency in meta‐analysis</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">327</span>(7414):557‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12958120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measuring+inconsistency+in+meta%E2%80%90analysis&author=JP+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0078"> <div class="reference-title-banner"> <h4 class="title">Higgins 2005</h4> </div> <div class="bibliography-section" id="CD006165-bib-0078"> <div class="citation-other">Higgins JPT, Green S, editors. <span class="citation-title">Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]</span>. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley &amp; Sons, Ltd. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0079"> <div class="reference-title-banner"> <h4 class="title">Higgins 2011</h4> </div> <div class="bibliography-section" id="CD006165-bib-0079"> <div class="citation-other">Higgins JPT, Green S (editors). <span class="citation-title">Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</span>. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0080"> <div class="reference-title-banner"> <h4 class="title">Kobayashi 1996</h4> </div> <div class="bibliography-section" id="CD006165-bib-0080"> <div class="citation-journal">Kobayashi T, Nakanishi K, Murase T, Kosaka K. <span class="citation-title">Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta‐cell failure in islet cell antibody‐positive patients with clinical features of NIDDM</span>. <span class="citation"> Diabetes </span><span class="pubYear">1996</span>;<span class="volume">45</span>(5):622‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8621013" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Small+doses+of+subcutaneous+insulin+as+a+strategy+for+preventing+slowly+progressive+beta%E2%80%90cell+failure+in+islet+cell+antibody%E2%80%90positive+patients+with+clinical+features+of+NIDDM+&author=T+Kobayashi&author=K+Nakanishi&author=T+Murase&author=K+Kosaka&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0081"> <div class="reference-title-banner"> <h4 class="title">Kobayashi 2002</h4> </div> <div class="bibliography-section" id="CD006165-bib-0081"> <div class="citation-journal">Kobayashi T, Maruyama T, Shimada A, Kasuga A, Kanatsuka A, Takei I, et al. <span class="citation-title">Insulin intervention to preserve beta cells in slowly progressive insulin‐dependent (type 1) diabetes mellitus</span>. <span class="citation"> Annals of the New York Academy of Sciences </span><span class="pubYear">2002</span>;<span class="volume">958</span>:117‐30. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12021091" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+intervention+to+preserve+beta+cells+in+slowly+progressive+insulin%E2%80%90dependent+(type+1)+diabetes+mellitus+&author=T+Kobayashi&author=T+Maruyama&author=A+Shimada&author=A+Kasuga&author=A+Kanatsuka&author=I+Takei&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0082"> <div class="reference-title-banner"> <h4 class="title">Lau 2006</h4> </div> <div class="bibliography-section" id="CD006165-bib-0082"> <div class="citation-journal">Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. <span class="citation-title">The case of the misleading funnel plot</span>. <span class="citation"> BMJ </span><span class="pubYear">2006</span>;<span class="volume">333</span>:597‐600. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16974018" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+case+of+the+misleading+funnel+plot&author=J+Lau&author=JPA+Ioannidis&author=N+Terrin&author=CH+Schmid&author=I+Olkin&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0083"> <div class="reference-title-banner"> <h4 class="title">Leslie 2006</h4> </div> <div class="bibliography-section" id="CD006165-bib-0083"> <div class="citation-journal">Leslie R.D, Williams D.R.R, Pozzelli P. <span class="citation-title">Type 1 diabetes and latent autoimmune diabetes in adults (LADA): one end of the rainbow</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">2006</span>;<span class="volume">91</span>(5):1654‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16478821" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Type+1+diabetes+and+latent+autoimmune+diabetes+in+adults+(LADA):+one+end+of+the+rainbow&author=R.D+Leslie&author=D.R.R+Williams&author=P+Pozzelli&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0084"> <div class="reference-title-banner"> <h4 class="title">Lewis 2001</h4> </div> <div class="bibliography-section" id="CD006165-bib-0084"> <div class="citation-journal">Lewis S, Clarke M. <span class="citation-title">Forest plots: trying to see the wood and the trees</span>. <span class="citation"> BMJ </span><span class="pubYear">2001</span>;<span class="volume">322</span>(7300):1479‐80. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11408310" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Forest+plots:+trying+to+see+the+wood+and+the+trees&author=S+Lewis&author=M+Clarke&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0085"> <div class="reference-title-banner"> <h4 class="title">Liberati 2009</h4> </div> <div class="bibliography-section" id="CD006165-bib-0085"> <div class="citation-journal">Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. <span class="citation-title">The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration</span>. <span class="citation"> PLoS Med </span><span class="pubYear">1999</span>;<span class="volume">6</span>(7):1‐28. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1371/journal.pmed.1000100" target="_blank"><span>10.1371/journal.pmed.1000100</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+PRISMA+statement+for+reporting+systematic+and+meta%E2%80%90analyses+of+studies+that+evaluate+interventions:+explanation+and+elaboration+&author=A+Liberati&author=DG+Altman&author=J+Tetzlaff&author=C+Mulrow&author=PC+G%C3%B8tzsche&author=JPA+Ioannidis&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0086"> <div class="reference-title-banner"> <h4 class="title">Lohmann 2001</h4> </div> <div class="bibliography-section" id="CD006165-bib-0086"> <div class="citation-journal">Lohmann T, Kellner K, Verlohren HJ, Krug J, Steindorf J, Scherbaum WA, et al. <span class="citation-title">Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA)</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2001</span>;<span class="volume">44</span>(8):1005‐10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11484077" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Titre+and+combination+of+ICA+and+autoantibodies+to+glutamic+acid+decarboxylase+discriminate+two+clinically+distinct+types+of+latent+autoimmune+diabetes+in+adults+(LADA)+&author=T+Lohmann&author=K+Kellner&author=HJ+Verlohren&author=J+Krug&author=J+Steindorf&author=WA+Scherbaum&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0087"> <div class="reference-title-banner"> <h4 class="title">Maruyama 2003</h4> </div> <div class="bibliography-section" id="CD006165-bib-0087"> <div class="citation-journal">Maruyama T, Shimada A, Kanatsuka A, Kasuga A, Takei I, Yokoyama J, et al. <span class="citation-title">Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report</span>. <span class="citation"> Annals of the New York Academy of Sciences </span><span class="pubYear">2003</span>;<span class="volume">1005</span>:362‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14679093" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Multicenter+prevention+trial+of+slowly+progressive+type+1+diabetes+with+small+dose+of+insulin+(the+Tokyo+study):+preliminary+report+&author=T+Maruyama&author=A+Shimada&author=A+Kanatsuka&author=A+Kasuga&author=I+Takei&author=J+Yokoyama&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0088"> <div class="reference-title-banner"> <h4 class="title">Nabhan 2005</h4> </div> <div class="bibliography-section" id="CD006165-bib-0088"> <div class="citation-journal">Nabhan F, Emanuele M, Emanuele N, Nabhan F. <span class="citation-title">Latent autoimmune diabetes of adulthood. Unique features that distinguish it from type 1 and 2</span>. <span class="citation"> Postgraduate Medicine </span><span class="pubYear">2005</span>;<span class="volume">117</span>(3):7‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15782668" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Latent+autoimmune+diabetes+of+adulthood.+Unique+features+that+distinguish+it+from+type+1+and+2+&author=F+Nabhan&author=M+Emanuele&author=N+Emanuele&author=F+Nabhan&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0089"> <div class="reference-title-banner"> <h4 class="title">Naik 2003</h4> </div> <div class="bibliography-section" id="CD006165-bib-0089"> <div class="citation-journal">Naik R, Palmer J. <span class="citation-title">Latent autoimmune diabetes in adults (LADA)</span>. <span class="citation"> Reviews in Endocrine and Metabolic Disorders </span><span class="pubYear">2003</span>;<span class="volume">4</span>:233‐41. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14501174" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Latent+autoimmune+diabetes+in+adults+(LADA)&author=R+Naik&author=J+Palmer&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0090"> <div class="reference-title-banner"> <h4 class="title">Naik 2009</h4> </div> <div class="bibliography-section" id="CD006165-bib-0090"> <div class="citation-journal">Naik RG, Brooks‐Worrell BM, Palmer JP. <span class="citation-title">Latent autoimmune diabetes in adults</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">2009</span>;<span class="volume">94</span>(12):4635‐44. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19837918" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Latent+autoimmune+diabetes+in+adults&author=RG+Naik&author=BM+Brooks%E2%80%90Worrell&author=JP+Palmer&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0091"> <div class="reference-title-banner"> <h4 class="title">Owen 2003</h4> </div> <div class="bibliography-section" id="CD006165-bib-0091"> <div class="citation-journal">Owen KR, Stride A, Ellard S, Hattersley AT. <span class="citation-title">Etiological investigation of diabetes in young adults presenting with apparent type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(7):2088‐93. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12832318" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Etiological+investigation+of+diabetes+in+young+adults+presenting+with+apparent+type+2+diabetes+&author=KR+Owen&author=A+Stride&author=S+Ellard&author=AT+Hattersley&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0092"> <div class="reference-title-banner"> <h4 class="title">Palmer 2002</h4> </div> <div class="bibliography-section" id="CD006165-bib-0092"> <div class="citation-journal">Palmer J. <span class="citation-title">Beta cell rest and recovery ‐ does it bring patients with latent autoimmune diabetes in adults to euglycaemia?</span>. <span class="citation"> Annals of the New York Academy of Sciences </span><span class="pubYear">2002</span>;<span class="volume">958</span>:89‐98. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12021087" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Beta+cell+rest+and+recovery+%E2%80%90+does+it+bring+patients+with+latent+autoimmune+diabetes+in+adults+to+euglycaemia?+&author=J+Palmer&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0093"> <div class="reference-title-banner"> <h4 class="title">Pozzilli 2001</h4> </div> <div class="bibliography-section" id="CD006165-bib-0093"> <div class="citation-journal">Pozzilli P, Mario U. <span class="citation-title">Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization and potential prevention</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2001</span>;<span class="volume">24</span>(8):1460‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11473087" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Autoimmune+diabetes+not+requiring+insulin+at+diagnosis+(latent+autoimmune+diabetes+of+the+adult):+definition,+characterization+and+potential+prevention+&author=P+Pozzilli&author=U+Mario&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0094"> <div class="reference-title-banner"> <h4 class="title">Richter 2006</h4> </div> <div class="bibliography-section" id="CD006165-bib-0094"> <div class="citation-journal">Richter Bernd, Bandeira‐Echtler Elizabeth, Bergerhoff Karla, Clar Christine, Ebrahim Susanne H. <span class="citation-title">Pioglitazone for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2006</span>, Issue 4. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858" target="_blank"><span>10.1002/14651858</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17054272" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pioglitazone+for+type+2+diabetes+mellitus&author=Bernd+Richter&author=Elizabeth+Bandeira%E2%80%90Echtler&author=Karla+Bergerhoff&author=Christine+Clar&author=H+EbrahimSusanne&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0095"> <div class="reference-title-banner"> <h4 class="title">Richter 2007</h4> </div> <div class="bibliography-section" id="CD006165-bib-0095"> <div class="citation-journal">Richter Bernd, Bandeira‐Echtler Elizabeth, Bergerhoff Karla, Clar Christine, Ebrahim Susanne H. <span class="citation-title">Rosiglitazone for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2007</span>, Issue 3. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858" target="_blank"><span>10.1002/14651858</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+for+type+2+diabetes+mellitus&author=Bernd+Richter&author=Elizabeth+Bandeira%E2%80%90Echtler&author=Karla+Bergerhoff&author=Christine+Clar&author=H+EbrahimSusanne&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0096"> <div class="reference-title-banner"> <h4 class="title">Richter 2008</h4> </div> <div class="bibliography-section" id="CD006165-bib-0096"> <div class="citation-journal">Richter B, Bandeira‐Echtler E, Bergerhoff K, Lerch CL. <span class="citation-title">Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2008</span>, Issue 2. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/CD006739.pub2" target="_blank"><span>CD006739.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Dipeptidyl+peptidase%E2%80%904+(DPP%E2%80%904)+inhibitors+for+type+2+diabetes+mellitus&author=B+Richter&author=E+Bandeira%E2%80%90Echtler&author=K+Bergerhoff&author=CL+Lerch&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0097"> <div class="reference-title-banner"> <h4 class="title">Saenz 2005</h4> </div> <div class="bibliography-section" id="CD006165-bib-0097"> <div class="citation-journal">Saenz Antonio, Fernandez‐Esteban Inmaculada, Mataix Angel, Ausejo Segura Monica, Roqué i Figuls Marta, Moher David. <span class="citation-title">Metformin monotherapy for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 3. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858" target="_blank"><span>10.1002/14651858</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16034881" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+monotherapy+for+type+2+diabetes+mellitus&author=Antonio+Saenz&author=Inmaculada+Fernandez%E2%80%90Esteban&author=Angel+Mataix&author=Monica+AusejoSegura&author=iFigulsMarta+Roqu%C3%A9&author=David+Moher&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0098"> <div class="reference-title-banner"> <h4 class="title">Schernthaner 2001</h4> </div> <div class="bibliography-section" id="CD006165-bib-0098"> <div class="citation-journal">Schernthaner G, Hink S, Kopp H, Muzyka B, Streit G, Kroiss A. <span class="citation-title">Progress in the characterization of slowly progressive autoimmune diabetes in adult patients (LADA or type 1.5 diabetes)</span>. <span class="citation"> Experimental Clinical Endocrinology Diabetes </span><span class="pubYear">2001</span>;<span class="volume">109</span>:S94‐S108. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11460597" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Progress+in+the+characterization+of+slowly+progressive+autoimmune+diabetes+in+adult+patients+(LADA+or+type+1.5+diabetes)+&author=G+Schernthaner&author=S+Hink&author=H+Kopp&author=B+Muzyka&author=G+Streit&author=A+Kroiss&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0099"> <div class="reference-title-banner"> <h4 class="title">Scranton 2004</h4> </div> <div class="bibliography-section" id="CD006165-bib-0099"> <div class="citation-other">Scranton R, Su M, Turner R, Testa M. <span class="citation-title">Quality of life considerations for insulin versus oral agent therapy in persons presenting with characteristics of latent autoimmune diabetes in adults [LADA]</span>. American Diabetes Association. <span class="pubYear">2004</span>:Abstract number: 1835‐P. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Quality+of+life+considerations+for+insulin+versus+oral+agent+therapy+in+persons+presenting+with+characteristics+of+latent+autoimmune+diabetes+in+adults+[LADA]+&author=R+Scranton&author=M+Su&author=R+Turner&author=M+Testa&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0100"> <div class="reference-title-banner"> <h4 class="title">Stenstrom 2005</h4> </div> <div class="bibliography-section" id="CD006165-bib-0100"> <div class="citation-journal">Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G. <span class="citation-title">Section II: Type 1‐ related forms of diabetes. Latent autoimmune diabetes in adults</span>. <span class="citation"> Diabetes </span><span class="pubYear">2005</span>;<span class="volume">54</span>:S68‐S72. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16306343" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Section+II:+Type+1%E2%80%90+related+forms+of+diabetes.+Latent+autoimmune+diabetes+in+adults&author=G+Stenstrom&author=A+Gottsater&author=E+Bakhtadze&author=B+Berger&author=G+Sundkvist&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0101"> <div class="reference-title-banner"> <h4 class="title">Sterne 2001</h4> </div> <div class="bibliography-section" id="CD006165-bib-0101"> <div class="citation-book">Sterne JAC, Egger M, Davey Smith G. <span class="citation-title">Investigating and dealing with publication and other biases</span>. In: Egger M, Davey Smith G, Altman DG editor(s). <span class="citation">Systematic Reviews in Health Care; Meta‐analysis in Context</span>. London: BMJ Publishing Group, <span class="pubYear">2001</span>:189‐208. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Investigating+and+dealing+with+publication+and+other+biases&author=JAC+Sterne&author=M+Egger&author=G+DaveySmith&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0102"> <div class="reference-title-banner"> <h4 class="title">Takeda 2002</h4> </div> <div class="bibliography-section" id="CD006165-bib-0102"> <div class="citation-journal">Takeda H, Kawasaki E, Shimizu I, Konoue E, Fujiyama M, Murao S, et al. <span class="citation-title">Clinical, autoimmune, and genetic characteristics of adult‐onset diabetic patients with GAD auto‐antibodies in Japan (Ehime Study)</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>(6):995‐1001. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12032105" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical,+autoimmune,+and+genetic+characteristics+of+adult%E2%80%90onset+diabetic+patients+with+GAD+auto%E2%80%90antibodies+in+Japan+(Ehime+Study)+&author=H+Takeda&author=E+Kawasaki&author=I+Shimizu&author=E+Konoue&author=M+Fujiyama&author=S+Murao&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0103"> <div class="reference-title-banner"> <h4 class="title">Takino 1998</h4> </div> <div class="bibliography-section" id="CD006165-bib-0103"> <div class="citation-journal">Takino H, Yamasaki H, Sera Y, Abe T, Ozaki M, Kondo H, et al. <span class="citation-title">The preliminary report from the nation‐wide prevention study for type 1 diabetes initially diagnosed as type 2 in Japan</span>. <span class="citation"> Diabetes/metabolism reviews </span><span class="pubYear">1998</span>;<span class="volume">14</span>(4):334‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+preliminary+report+from+the+nation%E2%80%90wide+prevention+study+for+type+1+diabetes+initially+diagnosed+as+type+2+in+Japan+&author=H+Takino&author=H+Yamasaki&author=Y+Sera&author=T+Abe&author=M+Ozaki&author=H+Kondo&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0104"> <div class="reference-title-banner"> <h4 class="title">Tuomi 1993</h4> </div> <div class="bibliography-section" id="CD006165-bib-0104"> <div class="citation-journal">Tuomi T, Groop L, Zimmet P, Rowley M, Knowles W, MacKay I, et al. <span class="citation-title">Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non‐insulin‐dependent onset of disease</span>. <span class="citation"> Diabetes </span><span class="pubYear">1993</span>;<span class="volume">42</span>:359‐62. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8425674" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antibodies+to+glutamic+acid+decarboxylase+reveal+latent+autoimmune+diabetes+mellitus+in+adults+with+a+non%E2%80%90insulin%E2%80%90dependent+onset+of+disease+&author=T+Tuomi&author=L+Groop&author=P+Zimmet&author=M+Rowley&author=W+Knowles&author=I+MacKay&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0105"> <div class="reference-title-banner"> <h4 class="title">Turner 1997</h4> </div> <div class="bibliography-section" id="CD006165-bib-0105"> <div class="citation-journal">Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, et al. <span class="citation-title">UKPDS 25: autoantibodies to islet‐cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group</span>. <span class="citation"> Lancet </span><span class="pubYear">1997</span>;<span class="volume">350 (9087)</span>:1288‐93. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=UKPDS+25:+autoantibodies+to+islet%E2%80%90cell+cytoplasm+and+glutamic+acid+decarboxylase+for+prediction+of+insulin+requirement+in+type+2+diabetes.+UK+Prospective+Diabetes+Study+Group+&author=R+Turner&author=I+Stratton&author=V+Horton&author=S+Manley&author=P+Zimmet&author=IR+Mackay&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0106"> <div class="reference-title-banner"> <h4 class="title">van de Laar 2006</h4> </div> <div class="bibliography-section" id="CD006165-bib-0106"> <div class="citation-journal">Laar FA, Lucassen PL, Akkermans RP, Lisdonk EH, Grauw WJ. <span class="citation-title">Alpha‐glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2006</span>, Issue 4. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/CD005061.pub2" target="_blank"><span>CD005061.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17054235" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Alpha%E2%80%90glucosidase+inhibitors+for+people+with+impaired+glucose+tolerance+or+impaired+fasting+blood+glucose+&author=FA+Laar&author=PL+Lucassen&author=RP+Akkermans&author=EH+Lisdonk&author=WJ+Grauw&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0107"> <div class="reference-title-banner"> <h4 class="title">Zhou 2004</h4> </div> <div class="bibliography-section" id="CD006165-bib-0107"> <div class="citation-journal">Zhou Z, Li X, Huang G, Peng J, Yang L, Yan X, et al. <span class="citation-title">Rosiglitazone combined with insulin preserves islet beta cell function in adult‐onset latent autoimmune diabetes (LADA)</span>. <span class="citation"> Diabetes/ Metabolism Research and Review </span><span class="pubYear">2004</span>;<span class="volume">21</span>(2):203‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+combined+with+insulin+preserves+islet+beta+cell+function+in+adult%E2%80%90onset+latent+autoimmune+diabetes+(LADA)+&author=Z+Zhou&author=X+Li&author=G+Huang&author=J+Peng&author=L+Yang&author=X+Yan&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006165-bbs2-0108"> <div class="reference-title-banner"> <h4 class="title">Zinman 2004</h4> </div> <div class="bibliography-section" id="CD006165-bib-0108"> <div class="citation-journal">Zinman B, Kahn SE, Haffner SM, O'Neill MC, Heise MA, Freed MI. <span class="citation-title">Phenotypic characteristics of GAD antibody‐positive recently diagnosed patients with type 2 diabetes in North America and Europe</span>. <span class="citation"> Diabetes </span><span class="pubYear">2004</span>;<span class="volume">53</span>(12):3193‐200. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15561950" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Phenotypic+characteristics+of+GAD+antibody%E2%80%90positive+recently+diagnosed+patients+with+type+2+diabetes+in+North+America+and+Europe+&author=B+Zinman&author=SE+Kahn&author=SM+Haffner&author=MC+O'Neill&author=MA+Heise&author=MI+Freed&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD006165-sec2-0020"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006165-sec2-0021" class="jump-to">excluded studies</a></li> <li><a href="#CD006165-sec2-0022" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Agardh 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> equal ratio to four groups </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: yes </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = yes, E = yes, R = unclear </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: no, exploratory trial </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Placebo: 7.7% F(1/13) :92% M (12/13), Group 1 (4μg): 22%F(2/9) :77%M (7/9), Group 2 (20μg): 25%F(2/8): 75%M (6/8), Group 3 (100 μg): 33%F(3/9):66%M (6/9), Group 4 (500μg): 0% F(0/8): 100% M (8/8). </p> <p><b>AGE (median years (range))</b>: Placebo:56 years (37‐66) Group 1 (4μg): 58 years (39‐69), Group 2 (20μg): 57 years (48‐67), Group 3 (100 μg):57 years (30‐69), Group 4 (500μg): 53 years (39‐62) </p> <p><b>ETHNIC GROUPS (%)</b>: not specified </p> <p><b>DURATION OF DISEASE (mean years (SD))</b>:Not given </p> <p><b>INCLUSION CRITERIA</b>:(1) Male or female aged 30‐70 years (2) diagnosed with type 2 diabetes within the previous 5 years (3) presence of GADA (4) only requiring diabetes treatment with diet, oral hypoglycaemic agents, or both (5) females of non‐child‐bearing potential (6) absence of associated serious diseases or conditions which, in the opinion of the investigator would exclude the patient from the trial (7) patients who had given written informed consent at the screening visit. </p> <p><b>EXCLUSION CRITERIA</b>: not specified </p> <p><b>DIAGNOSTIC CRITERIA</b>: Diagnosed with type 2 diabetes within the previous 5 years, presence of GADA, only requiring treatment with diet, oral hypoglycaemic agents or both. </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Placebo: 13, Group 1 (4μg): 9, Group 2 (20μg): 8, Group 3 (100 μg): 9, Group 4 (500μg): 8 </p> <p><b>LOSS TO FOLLOW‐UP</b>: 0% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:2 </p> <p><b>COUNTRY/ LOCATION</b>: Sweden </p> <p><b>SETTING</b>: out patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: dose comparison of subcutaneous GAD (Diamyd) injections at 4 ug, 20 ug, 100 ug or 500 ug doses </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: placebo (Alhydrogel) </p> <p><b>TREATMENT BEFORE STUDY</b>: All intervention patients received 4μg for 8 weeks. If there were no safety concerns then the higher dose (20 μg or 100 μg or 500μg) was initiated. </p> <p><b>TITRATION PERIOD</b>: No applicable. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>: Not stated but objective states "Investigate the clinical safety of subcutaneously administered Diamyd" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Note stated but objectives states "Assess the impact of Diamyd on the immune system and diabetic status" </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>Collected at baseline and 24 weeks. <br> 1. HbA1c (%), 2. Fasting blood glucose (mmol/L), 3. Log GADA (U/ml), 4. C‐peptide (nmol/L), 5. BMI (kg/m2), 6. Adverse events </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 24 weeks </p> <p><b>DURATION OF FOLLOW‐UP</b>: 24 weeks </p> <p><b>RUN‐IN PERIOD</b>: 8 weeks in the intervention group (4μg for 8 weeks before higher dose initiated) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>:English </p> <p><b>COMMERCIAL FUNDING</b>: yes </p> <p><b>NON‐COMMERCIAL FUNDING:</b> no </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b> no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> " To investigate the clinical safety of subcutaneously administered Diamyd and to assess its impact on the immune system and diabetic status" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not given</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear how allocation was designed</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No incomplete outcome data given</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Funded with support from Diamyd Therapeutics and authorship from a member of Diamyd</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Agardh 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> equal ratio to four groups </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: yes </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = yes, E = yes, R = unclear </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: no, exploratory trial. However, manuscript states "the study was carried out according to the intention‐to‐treat principle" </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Placebo: 7.7% F(1/13) :92% M (12/13), Group 1 (4μg): 22%F(2/9) :77%M (7/9), Group 2 (20μg): 25%F(2/8): 75%M (6/8), Group 3 (100 μg): 33%F(3/9):66%M (6/9), Group 4 (500μg): 0% F(0/8): 100% M (8/8) </p> <p><b>AGE (median years (range))</b>: Placebo:56 years (37‐66) Group 1 (4μg): 58 years (39‐69), Group 2 (20μg): 57 years (48‐67), Group 3 (100 μg):57 years (30‐69), Group 4 (500μg): 53 years (39‐62) </p> <p><b>ETHNIC GROUPS (%)</b>: not specified </p> <p><b>DURATION OF DISEASE (mean years (SD))</b>:Not given </p> <p><b>INCLUSION CRITERIA</b>:(1) Male or female aged 30‐70 years (2) diagnosed with type 2 diabetes within the previous 5 years (3) presence of GADA (4) only requiring diabetes treatment with diet, oral hypoglycaemic agents, or both (5) females of non‐child‐bearing potential (6) absence of associated serious diseases or conditions which, in the opinion of the investigator would exclude the patient from the trial (7) patients who had given written informed consent at the screening visit. </p> <p><b>EXCLUSION CRITERIA</b>: not specified </p> <p><b>DIAGNOSTIC CRITERIA</b>: Diagnosed with type 2 diabetes within the previous 5 years, presence of GADA, only requiring treatment with diet, oral hypoglycaemic agents or both. </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Placebo: 13, Group 1 (4μg): 9, Group 2 (20μg): 8, Group 3 (100 μg): 9, Group 4 (500μg): 8 </p> <p><b>LOSS TO FOLLOW‐UP</b>: 14.9% (7/47) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:2 </p> <p><b>COUNTRY/ LOCATION</b>: Sweden </p> <p><b>SETTING</b>: out patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: dose comparison of subcutaneous GAD (Diamyd) injections at 4 ug, 20 ug, 100 ug or 500 ug doses </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: placebo (Alhydrogel) </p> <p><b>TREATMENT BEFORE STUDY</b>: All intervention patients received 4μg for 8 weeks. If there were no safety concerns then the higher dose (20 μg or 100 μg or 500μg) was initiated. </p> <p><b>TITRATION PERIOD</b>: No applicable. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>: Not stated but objectives states "evaluate long term clinical safety" Investigate the clinical safety of subcutaneously administered Diamyd </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated but objectives states "evaluate dose level effects on beta cell function". </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>1. GAD65, 2. IA‐2A, IAA, ICAs, 3. BMI, serum creatinine, lipid profile, 4. HbA1c (%), 5. Fasting blood glucose (mmol/L), 6. fasting and stimulated C‐peptide (nmol/L), 7. Adverse events </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 5 years </p> <p><b>DURATION OF FOLLOW‐UP</b>: 5 years </p> <p><b>RUN‐IN PERIOD</b>: 8 weeks in the intervention group (4μg for 8 weeks before higher dose initiated) ‐ taken from previous publication </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>:English </p> <p><b>COMMERCIAL FUNDING</b>: yes </p> <p><b>NON‐COMMERCIAL FUNDING:</b> no </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b> no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> " To evaluate long‐term clinical safety and dose level effects on beta cell function" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: This study is a follow‐up of <a href="references#CD006165-bbs2-0001">Agardh 2005</a> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"Randomisation was concealed by the clinical research organisation monitoring the study without any involvement by study investigators" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants, health care professionals and researchers blinded.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Loss to follow‐up of 15% of participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problem identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Funded with support from Diamyd Therapueutics</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Cabrera‐Rode 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> equal ratio assumed (not stated in manuscript) </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: unclear (not stated) </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = no </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: not stated. No loss to follow‐up </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Insulin+SU: 66%F(4/6): .33% M (2/6). Insulin: 38%F (3/8): 62%M (5/8) </p> <p><b>AGE (mean years (SD))</b>: Insulin+SU: 53.5 (16.9), Insulin: 53.0 (6.4) </p> <p><b>ETHNIC GROUPS (%)</b>: not specified </p> <p><b>DURATION OF DISEASE (mean years (SD))</b>:Insulin + SU: 1.5 yrs (1.8), Insulin: 2.0 yrs (2.6) </p> <p><b>INCLUSION CRITERIA</b>: Type 2 diabetic patients with ICA (&gt;20 JDF U) and GADA65A (on at least two consecutive tests) previously treated with glibenclamide and insulin (for at least 1 month) without history of ketonuria and diabetic ketoacidosis. </p> <p><b>EXCLUSION CRITERIA</b>: not specified </p> <p><b>DIAGNOSTIC CRITERIA</b>: Diagnosed with type 2 diabetes with ICA and GADA </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Insulin + SU: 6, Insulin: 8 </p> <p><b>LOSS TO FOLLOW‐UP</b>: 0% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>: not given </p> <p><b>COUNTRY/ LOCATION</b>: Cuba </p> <p><b>SETTING</b>: out patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: insulin therapy </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: insulin therapy plus sulphonylurea (glibenclamide) </p> <p><b>TREATMENT BEFORE STUDY</b>: Previously treated with glibenclamide and insulin (for at least 1 month) </p> <p><b>TITRATION PERIOD</b>: Not given </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>: Not stated but objectives states "evaluate if exclusion of glibenclamide may diminish levels of ICA and anti GADA65 antibodies" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated but objectives states "evaluate if exclusion of glibenclamide may improve fasting glucose and insulin secretion". </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>Collected at baseline and 12 months : 1. Fasting blood glucose (mmol/L), 2. Fasting C‐peptide (pmol/L), 3. BMI (kg/m2), 4. Insulin dose (U/day), 5. SU (glibenclamide, mg/day) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 12 months </p> <p><b>DURATION OF FOLLOW‐UP</b>: 12 months </p> <p><b>RUN‐IN PERIOD</b>: Treatment with glibenclamide and insulin for at least 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: no </p> <p><b>NON‐COMMERCIAL FUNDING:</b> yes </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b> no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> "to evaluate whether the exclusion of glibenclamide in the treatment of ICA positive type 2 diabetic patients may diminish the levels of ICA and anti‐GAD65 autoantibodies as well as improve fasting glucose and insulin secretion " </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No description given</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded trial but there was no evidence that the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No participants lost to follow‐up</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c was not reported however FBG was reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problem identified</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Davis 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> equal ratio assumed (not stated in manuscript) </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: yes </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = unclear </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: Yes </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: unable to distinguish by treatment groups. Of total antibody positive group 56% (n=293/536) were male </p> <p><b>AGE (mean years (SD))</b>: unable to distinguish by treatment groups. Of total antibody positive group, average age 48.2 (SD: 10.8) </p> <p><b>ETHNIC GROUPS (%)</b>: unable to distinguish by treatment groups. Of total antibody positive group; WC (initials not explained in text so assumed white Caucasian): 93%, AC (initials not explained in text but assumed African/Carabean): 2%, IA (initials not explained in text but assumed Indian/Asian): 5%, other 0% </p> <p><b>DURATION OF DISEASE (mean years (SD))</b>: Newly diagnosed. Average disease duration not stated </p> <p><b>INCLUSION CRITERIA</b>: aged 25‐65 years with type 2 diabetes and fasting plasma glucose above 6.0 mmol/L on two subsequent occasions. </p> <p><b>EXCLUSION CRITERIA</b>: Exclusion criteria (1) severe vasculare disease, (2) accelerated hypertension (3) proliferative retinopathy (4) renal failure (5) other life threatening disease (6) illness requiring systemic steroids (7) occupation precluding insulin treatment (8) unable to speak English (9) ketonuria greater than 3 mmol// suggestive of type 1 diabetes. </p> <p><b>DIAGNOSTIC CRITERIA</b>: Type 2 diabetes newly diagnosed by general practitioner and fasting plasma glucose higher than 6.0 mmol/L on two subsequent occasions. </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Group FPG 60.‐14.9 mmol/L : insulin: 95, SU: 140, Conventional: 100 </p> <p>Group FPG&gt;15 mmol/L : insulin 65, SU 88.</p> <p><b>LOSS TO FOLLOW‐UP</b>: not given </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:23 centres </p> <p><b>COUNTRY/ LOCATION</b>: UK </p> <p><b>SETTING</b>: general practitioner/out‐patients </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: Baseline FPG 6.0‐14 mmol/L: Insulin OR SU. Baseline FPG&gt;15 mmol/L: Insulin </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: Baseline FPG 6.0‐14 mmol/L. Conventional care. Baseline FPG&gt;15 mmol/L: SU. </p> <p><b>TREATMENT BEFORE STUDY</b>: All patients entered a 3‐4 month dietary run‐in period, during which they were advised to take a diet containing 50% carbohydrate, with low saturated fat, high fibre. </p> <p><b>TITRATION PERIOD</b>: None </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>: Not stated but objectives states "examine the effect of autoantibody status on glycaemic response to therapy" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated but objectives states "assess the association between autoantibody status and cardiovascular risk". </p> <p><b>ADDITIONAL OUTCOMES</b>: Recorded annually: HbA1c, weight </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 10 years </p> <p><b>DURATION OF FOLLOW‐UP</b>: 10 years </p> <p><b>RUN‐IN PERIOD</b>: 3‐ 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: yes </p> <p><b>NON‐COMMERCIAL FUNDING:</b> yes </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b>no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> "to examine objectively the effect of autoantibody status on glycaemic response to therapy and to assess the association between autoantibody status and cardiovascular risk " </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded but there was no evidence that the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described (i.e. loss to follow‐up)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No record of mortality, C‐peptide or intention to treat analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Commercial sponsorship gives potential for bias</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kobayashi 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> equal ratio </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: unclear </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = unclear </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: no (not stated in manuscript) </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Insulin 30%F (2/5): 60% M (3/5), SU 30% F (2/5) : 60% M(3/5) </p> <p><b>AGE (mean years (SD))</b>: Insulin: 51 years (8), SU 48 yrs (11) </p> <p><b>ETHNIC GROUPS (%)</b>: not stated </p> <p><b>DURATION OF DISEASE (mean years (SD))</b>: insulin 0.7 yrs (1.1), SU 1.5 yrs (2.1) </p> <p><b>INCLUSION CRITERIA</b>: (1) disease diagnosed according to the National Diabetes Data Group (2) ICA positive (3) patients were not related to each other </p> <p><b>EXCLUSION CRITERIA</b>: (1) history of ketonuria, diabetic ketoacidosis or marked hypoglycaemia initially requiring insulin </p> <p><b>DIAGNOSTIC CRITERIA</b>: Type 2 diabetes newly diagnosed by general practitioner and fasting plasma glucose higher than 6.0 mmol/L on two subsequent occasions. </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Insulin 5, SU 5. </p> <p><b>LOSS TO FOLLOW‐UP</b>: 0% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:not given </p> <p><b>COUNTRY/ LOCATION</b>: Japan </p> <p><b>SETTING</b>: out‐patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: small doses of sub‐cutaneous insulin </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: sulphonylurea (glibenclamide) </p> <p><b>TREATMENT BEFORE STUDY</b>:Diet therapy before study entry. Consume a diet containing 30 kcal per kg ideal body weight per day with 55%‐60% carbohydrate. </p> <p><b>TITRATION PERIOD</b>:None </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>: Not stated but objectives states "effects of small doses of insulin in patients with NIDDM who were ICA positive" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>Collected at baseline and 30 months. <br> 1. HbA1c (%), 2. Fasting blood glucose (mmol/L) 3. Change in serum C‐peptide to OGTT 4.. 2‐hr blood glucose (mmol/L), 5. BMI (kg/m2), 5. Insulin dose (U/day), 6. ICA titre. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 30 months </p> <p><b>DURATION OF FOLLOW‐UP</b>: 30 months </p> <p><b>RUN‐IN PERIOD</b>: Not given </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: no </p> <p><b>NON‐COMMERCIAL FUNDING:</b> yes </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b>no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> " conduct a prospective pilot study on the effects of small doses of insulin in patients with presumed NIDDM who were ICA and thus at high risk for progression to insulin dependence" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not given in manuscript</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded but there was no evidence that the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">L‐Hallin 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> 75% placebo (insulin + placebo) and 25% intervention (insulin + SU) </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: yes </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = unclear </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: no (not stated in manuscript) </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>:Placebo (insulin + placebo): 58% F (7/12), 48% M (5/12), SU (insulin+SU) 0% F (0/3), 100% M (3/3) </p> <p><b>AGE (mean years (SD))</b>: Placebo (insulin+ placebo) 56.4 yrs, SU (insulin+ SU): 60 yrs </p> <p><b>ETHNIC GROUPS (%)</b>: not specified </p> <p><b>DURATION OF DISEASE (mean years (SD))</b>: not reported for antibody positive patients only </p> <p><b>INCLUSION CRITERIA</b>: (1) type 2 diabetic patients (the findings from the study's 15 GAD positive patients were of relevance to this review) (2) 35‐75 years old (3) BMI 22‐32 kg/m2 (4) previous successful response to sulphonylurea (5) fasting blood glucose &gt; 8 mmol/L and/or a postprandial blood glucose &gt; 11 mmol/L and/or an HbA1c &gt; 3% above normal per local standard, despite treatment with maximal doses of SU for at least 3 months </p> <p><b>EXCLUSION CRITERIA</b>: (1) renal disease (2) liver dysfunction (3) concurrent acute disease </p> <p><b>DIAGNOSTIC CRITERIA</b>:Type 2 diabetes GAD antibodies </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Placebo (insulin+placebo) 12, SU (insulin + SU) 3 </p> <p><b>LOSS TO FOLLOW‐UP</b>: 13.3% (2/15) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:9 </p> <p><b>COUNTRY/ LOCATION</b>: Sweden </p> <p><b>SETTING</b>: out‐patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: Sulphonylurea (glibenclamide) and premix insulin for 8 months </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: Sulphonylurea (glibenclamide) and premix insulin for 4 months, then premix insulin alone for 4 months </p> <p><b>TREATMENT BEFORE STUDY</b>:Run‐in period for 1‐2 weeks, SU treatment was standardized to 10.5mg glibenclamide daily. Then 4 months on premixed insulin in combination with open glibenclamide. </p> <p><b>TITRATION PERIOD</b>: The insulin dose was increased every 2‐4 weeks during the first three months to achieve satisfactory metabolic control </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>: Not stated but objectives states "identifying responders to combined glibenclamide and insulin treatment and predictors of such response, in patients no longer able to achieve acceptable metabolic control with SU alone" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>Collected at baseline, 4 and 8 months. <br> 1. Fasting blood glucose (mmol/L), 2. HbA1c (%), 3. Fasting C‐peptide (nmol/L), 4. Free P‐insulin (mU/L),5. KITT (%/min), 6. Weight (kg) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 8 months in total </p> <p><b>DURATION OF FOLLOW‐UP</b>: 8 months </p> <p><b>RUN‐IN PERIOD</b>:4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: yes </p> <p><b>NON‐COMMERCIAL FUNDING:</b> yes </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT): n</b>o </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> "Identifying responders to combined glibenclamide and insulin treatment and predictors of such response, in patients no longer able to achieve acceptable metabolic control " </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded but there was no evidence that the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problem identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Commerical funding from Aventis</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Li 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> equal ratio assumed (not stated in manuscript) </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: yes </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = unclear </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: no, ITT not reported in the paper </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Insulin 27%F (5/18): 72% M (13/18), Insulin+Vit D 17.6% F (3/17) : 82.4% M(14/17) </p> <p><b>AGE (mean years (SD))</b>: Insulin: 42.8 years (12.9), Insulin+Vit D 38.5 yrs (12.5) </p> <p><b>ETHNIC GROUPS (%)</b>: not stated </p> <p><b>DURATION OF DISEASE (median years (range))</b>: insulin 0.5 yrs (0.1‐4.0), Insulin + Vit D 1.0 yrs (0.1‐4.0) </p> <p><b>INCLUSION CRITERIA</b>: (1) age to onset over 20 years (2) no ketosis within the first 6 months after diagnosis (3) disease duration less than 5 years (4) autoantibodies to GADA positive twice within one month and (5) fasting C‐peptide (FCP) &gt; 200 pmol/L at entry. </p> <p><b>EXCLUSION CRITERIA</b>: (1) patients with liver or kidney disorders (alanine aminotransferase or aspartate aminotransferase &gt; 2.5‐fold of upper normal limit, total bilirubin &gt; 1.5 U/mL or blood creatinine &gt; 15 mg/dL (2) premenopausal women who did not use effective contraception, or any pregnant women (3) patients who have had any severe systemic disease such as heart failure, cancer, stroke, or recent surgery. </p> <p><b>DIAGNOSTIC CRITERIA</b>: Diabetes diagnosed according to American Diabetes Association (ADA) standards </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Insulin 18, Insulin+Vit D 17 </p> <p><b>LOSS TO FOLLOW‐UP</b>: 0% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:not given </p> <p><b>COUNTRY/ LOCATION</b>: China </p> <p><b>SETTING</b>: not given </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: both groups treated with mixed human Insulin (Novolin 30 R or Humulin 70/30). Vit D group was Alpha‐calcidol 0.25 ug bid for 12 months glibenclamide) and premix insulin for 8 months </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: both groups treated with mixed human Insulin (Novolin 30 R or Humulin 70/30). </p> <p><b>TREATMENT BEFORE STUDY</b>:None </p> <p><b>TITRATION PERIOD</b>:None </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>: Not stated but objectives states "possible benefits of 1‐α‐hycroxyvitamin C3 combined with insulin on beta‐cell function" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>Collected at baseline and 12 months. <br> 1. Fasting C‐peptide 2. 2‐h postprandial C‐peptide (PCP) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 12 months </p> <p><b>DURATION OF FOLLOW‐UP</b>: 12 months </p> <p><b>RUN‐IN PERIOD</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: no </p> <p><b>NON‐COMMERCIAL FUNDING:</b> yes </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b>no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> " to study the possible benefits of 1‐α‐hydroxyvitamin D3 combined with insulin on β‐cell function in LADA" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded but there was no evidence that the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c was not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Maruyama 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel </p> <p><b>RANDOMISATION RATIO:</b> equal ratio assumed (not stated in manuscript) </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: unclear </p> <p><b>PATIENT CONSENT OBTAINED:</b> unclear </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = unclear </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: No, not stated in the manuscript </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Insulin 37.5%F (9/24): 62.5% M (15/24), SU 53% F (16/30) : 47% M(14/30) </p> <p><b>AGE (mean years (SD))</b>: Insulin: 56.6 years (13.4), SU 50.4 yrs (14.1) </p> <p><b>ETHNIC GROUPS (%)</b>: not stated </p> <p><b>DURATION OF DISEASE (mean years (SD))</b>: insulin 2.7 yrs (3.8), SU 2.4 yrs (2.9) </p> <p><b>INCLUSION CRITERIA</b>: (1) diagnosis of diabetes according to ADA criteria (2) not treated with insulin at least 6 months after diagnosis of diabetes (3) positive GADA in 2 samples taken within 2 months (4) disease duration &lt; 10 years (5) patients were unrelated </p> <p><b>EXCLUSION CRITERIA</b>: (1) history of ketonuria, diabetic ketoacidosis, marked hyperglycaemia requiring insulin, (2) renal or hepatic dysfunction affecting C‐peptide clearance and glucose tolerance, </p> <p><b>DIAGNOSTIC CRITERIA</b>: Diabetes diagnosed according to American Diabetes Association (ADA) standards </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Insulin 24, SU 30 </p> <p><b>LOSS TO FOLLOW‐UP</b>: unclear 54 reported at baseline but 56 reported at 48 months. Assumed typo and 54 participants with no loss of follow‐up. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:7 </p> <p><b>COUNTRY/ LOCATION</b>: Japan </p> <p><b>SETTING</b>: out‐patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: subcutaneous insulin therapy </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: sulphonylurea (glibenclamide) </p> <p><b>TREATMENT BEFORE STUDY</b>:None </p> <p><b>TITRATION PERIOD</b>: None </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>:Not stated but objectives states "to clarify the frequency of GADA positive patients with non insulin requiring diabetes" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated but objectives states "to clarify the natural course of these GADA positive patients and to know the preventive effect of insulin on progressive beta cell failure" </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>Collected at baseline and 4 years. <br> 1. Stimulated C‐peptide and change in C‐peptide response (ng/ml), 2. Blood glucose, 3. HbA1c (%), 4. GADA (U/ml) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 4 years </p> <p><b>DURATION OF FOLLOW‐UP</b>: 4 years (with 3‐monthly assessments) </p> <p><b>RUN‐IN PERIOD</b>: None </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: not reported </p> <p><b>NON‐COMMERCIAL FUNDING:</b> not reported </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b> no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> "to clarify the efficacy of small dose of insulin for progressive beta cell failure " </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded but there was no evidence that the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified (typo suspected on number of patients completing trial)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sponsorship not reported</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Maruyama 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> equal ratio assumed (not stated in manuscript) </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: yes </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = unclear </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: No, not stated in the manuscript </p> <p><b>POWER CALCULATION</b>: yes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Insulin 43%F (13/30): 57% M (17/30), SU 46% F (14/30) : 53% M(16/30) </p> <p><b>AGE (mean years (SD))</b>: Insulin: 54 years (13), SU 51 yrs (13) </p> <p><b>ETHNIC GROUPS (%)</b>: not stated </p> <p><b>DURATION OF DISEASE (mean years (SD))</b>: insulin 1.7 yrs (1.9), SU 1.9 yrs (1.7) </p> <p><b>INCLUSION CRITERIA</b>: (1) diagnosis of diabetes according to ADA criteria (2) not treated with insulin at least 6 months after diagnosis of diabetes (3) positive GADA in 2 samples taken within 2 months (4) disease duration &lt; 10 years (5) patients were unrelated </p> <p><b>EXCLUSION CRITERIA</b>: (1) history of ketonuria, diabetic ketoacidosis, marked hyperglycaemia requiring insulin, (2) renal or hepatic dysfunction affecting C‐peptide clearance and glucose tolerance, </p> <p><b>DIAGNOSTIC CRITERIA</b>: Diabetes diagnosed according to American Diabetes Association (ADA) standards </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Insulin 30, SU 30 </p> <p><b>LOSS TO FOLLOW‐UP</b>: 0% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:7 </p> <p><b>COUNTRY/ LOCATION</b>: Japan </p> <p><b>SETTING</b>: out‐patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: subcutaneous insulin therapy </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: sulphonylurea (glibenclamide) </p> <p><b>TREATMENT BEFORE STUDY</b>:None </p> <p><b>TITRATION PERIOD</b>: None. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>:Not stated but objectives states "to examine the ability of insulin to prevent progressive beta‐cell dysfunction in SPIDDM" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>Collected at baseline and 4 years. <br> 1. Stimulated C‐peptide and change in C‐peptide response (ng/ml), 2. Blood glucose, 3. HbA1c (%), 4. GADA (U/ml) 5. insulin dependent state 6. BMI </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 5 years </p> <p><b>DURATION OF FOLLOW‐UP</b>: 5 years (with 3‐monthly assessments) </p> <p><b>RUN‐IN PERIOD</b>: None </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: not reported </p> <p><b>NON‐COMMERCIAL FUNDING:</b> not reported </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b> no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> "to examine the ability of insulin to prevent progressive ß‐cell dysfunction in SPIDDM " </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Comment:</b> This is a follow‐up study from <a href="references#CD006165-bbs2-0005">Kobayashi 1996</a> and <a href="references#CD006165-bbs2-0008">Maruyama 2003</a> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Patients were randomly assigned using a centralized, masked‐draw system.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded but there was no evidence that the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sponsorship not reported</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Thunander 2010 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> Patient preference randomised controlled trial (incomplete randomisation as patients refusing insulin were not analysed within the insulin arm as per ITT but were considered within the tablet arm). </p> <p><b>RANDOMISATION RATIO:</b> randomised into two groups in blocks of eight </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: yes </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = no </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: reported to use intention to treat analysis but not evidence this was performed </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Conventional treatment group; 42% F (7/17), 58.8% M (10/17), insulin group 55% F(11/20), 45% M (9/20) </p> <p><b>AGE (mean years (SD))</b>: Conventional treatment group = 57.8 ± 15.1, Insulin group = 51.0 ± 14.3 </p> <p><b>ETHNIC GROUPS (%)</b>: not stated </p> <p><b>DURATION OF DISEASE (median months (range))</b>:Conventional treatment group = 5.0 [range 1 to 22], Insulin group = 6.0 [range: 1.5 to 24] </p> <p><b>INCLUSION CRITERIA</b>: (1) diagnosis of diabetes (2) aged &gt;30 yrs (3) not insulin requiring at diagnosis (3) GAD antibodies or ICA antibodies. </p> <p><b>EXCLUSION CRITERIA</b>: (1) mental conditions or severe physical illness. </p> <p><b>DIAGNOSTIC CRITERIA</b>: Diagnosed with diabetes with at least one of GADA or ICA </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Conventional treatment group 17, Insulin 20 </p> <p><b>LOSS TO FOLLOW‐UP</b>:Conventional treatment group = 2 out of 17 lost at 36 months, Insulin group = 2 out of 20 lost at 36 months. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:2 </p> <p><b>COUNTRY/ LOCATION</b>: Sweden </p> <p><b>SETTING</b>: out‐patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: subcutaneous insulin therapy starting with 2‐6 units intermediate‐acting insulin at night. </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: diet +/‐ oral hypoglycaemic agents (metformin and or SU) </p> <p><b>TREATMENT BEFORE STUDY</b>:None </p> <p><b>TITRATION PERIOD</b>: None. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>:Not stated but objectives states "to investigate the effect of early insulin treatment of LADA patients on residual beta‐cell function compared to a group initially treated with diet and/or oral hypoglycaemic agents" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated but objectives states "to investigate the effect of early insulin treatment of LADA patients on metabolic control compared to a group initially treated with diet and/or oral hypoglycaemic agents" </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>Collected at baseline and 12 months, 24 months and 36 months</p> <p>1.HbA1c, 2. Glucagon‐stimulated C‐peptide and changes in C‐peptide were measured.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>:36 months </p> <p><b>DURATION OF FOLLOW‐UP</b>: 36 months </p> <p><b>RUN‐IN PERIOD</b>:None </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: no </p> <p><b>NON‐COMMERCIAL FUNDING:</b> yes </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b> no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> "To investigate the effect of early insulin treatment of LADA patients, during three years, on residual beta‐cell function and metabolic control, compared to a group initially treated with diet and/or hypoglycaemic agents (OHA) " </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Pre‐prepared envelopes were used which is a less robust method compared to phone or Internet allocation. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There was no evidence that the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intention to treat was reported but no evidence that it was used. i.e. last result carried forward for those lost to follow‐up, analysis within the insulin arm of those randomised to insulin but choosing to be treated with conventional medication. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Xu 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> Equal numbers assumed (not stated in publication) </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: not clear </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = no </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: no, not reported </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: TYK and insulin group 38% F(14/37), 62% M(23/37), insulin group 35% F(13/37), 64% M (24/37) </p> <p><b>AGE (mean years (SD))</b>: TYK and insulin group = 39.51 ± 10.6, Insulin group = 38.7 ± 8.1 </p> <p><b>ETHNIC GROUPS (%)</b>: not stated </p> <p><b>DURATION OF DISEASE (median months (range))</b>:unclear </p> <p><b>INCLUSION CRITERIA</b>: unclear </p> <p><b>EXCLUSION CRITERIA</b>:unclear </p> <p><b>DIAGNOSTIC CRITERIA</b>: unclear </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> TYK + insulin 37, Insulin 37 </p> <p><b>LOSS TO FOLLOW‐UP</b>: not clear </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:1 </p> <p><b>COUNTRY/ LOCATION</b>: China </p> <p><b>SETTING</b>: out‐patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: subcutaneous insulin therapy and oral TKY. Insulin injection 0.5 u/kg daily 2/3 of the amount injected 30 min before breakfast 1/3 of the amount injected 30min before supper, adjusted according to blood sugar level. TKY consisted of red ginseng 10g, milkvetch root 30g, lilyturf root 15g, wild weed 10g, coptis root 15g, cape‐jasmine fruit 10g, giant knotweed rhizome 10g, safflower 10g, and moutain bark 10g. </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: subcutaneous insulin therapy (as described above) </p> <p><b>TREATMENT BEFORE STUDY</b>:None </p> <p><b>TITRATION PERIOD</b>: None. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>:Not stated but objectives states "to investigate the effect and mechanism of TKY for improving pancreatic islet beta cell function in patients with LADA" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>1.HbA1c, 2. Stimulated C‐peptide and changes in C‐peptide were measured 3. Inflammatory markers (IFN‐y and IL‐4) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 3 months </p> <p><b>DURATION OF FOLLOW‐UP</b>: 3 months </p> <p><b>RUN‐IN PERIOD</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: Chinese </p> <p><b>COMMERCIAL FUNDING</b>: no </p> <p><b>NON‐COMMERCIAL FUNDING</b>: yes </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b> no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> " To investigate the effect and mechanism of TYK for improving pancreatic islet ß cell function in patients with LADA " </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random number table</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No evidence the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear if there were losses to follow‐up</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Yang 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> equal ratio assumed (not stated in manuscript) </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: yes </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = no </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: No </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Insulin group 42% F(5/12), 58% M 7/12, Insulin plus rosiglitazone 50% F (6/12), 50% M (6/12), SU group 43% F (6/14), 57% M (8/14), Rosiglitazone group 33% F(5/15), 66% M (10/15) 10M, 5F. </p> <p><b>AGE (mean years (SD))</b>: Insulin group 48.5 (14.6), Insulin plus rosiglitazone 48.0 (12.8), SU group 50.0 (14.5), Rosiglitazone group 50.6 (11.8) </p> <p><b>ETHNIC GROUPS (%)</b>: not stated </p> <p><b>DURATION OF DISEASE (median months (range))</b>: Insulin 1.35 (1.52), Insulin + rosiglitazone 1.5 (1.52), SU group 1.1 (1.31), Rosiglitazone 1.16 (1.46). </p> <p><b>INCLUSION CRITERIA</b>: (1) No ketosis within the first 6 months after diagnosis (2) disease duration less than 5 years (3) FCP level of 0.2 nmol/L or more (4) diet alone can not achieve glycaemic control. </p> <p><b>EXCLUSION CRITERIA</b>: impaired liver, kidney or heart function or other severe diseases. </p> <p><b>DIAGNOSTIC CRITERIA</b>: type 2 diabetes diagnosed as LADA </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Insulin 12, Insulin + rosiglitazone 12, SU 14, Rosiglitazone 15. </p> <p><b>LOSS TO FOLLOW‐UP</b>: 0% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:not reported </p> <p><b>COUNTRY/ LOCATION</b>: China </p> <p><b>SETTING</b>: out‐patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: Patients with GADA &lt;175 and FCP &gt;0.3 nmol/L were randomised to SU. Patinets with GADA&lt;175 U/ml and FCP &lt;0.3 nmol/L were assigned subcutaneous insulin with rosiglitazone 4 mg/d. </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: Patients with GADA &lt;175 and FCP&gt;0.3 nmol/L were randomised to rosiglitazone 4 mg/d. Patients with GADA &lt;175 U/ml and FCP &lt;0.3 nmol/L were assigned subcutaneous insulin therapy </p> <p><b>TREATMENT BEFORE STUDY</b>:None </p> <p><b>TITRATION PERIOD</b>: None. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>:Not stated but objectives states "to clarify whether LADA benefit from rosiglitazone treatment" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>1.HbA1c, 2. FBG, 3. Stimulated C‐peptide and changes in C‐peptide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 36 months </p> <p><b>DURATION OF FOLLOW‐UP</b>: 36 months </p> <p><b>RUN‐IN PERIOD</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: no </p> <p><b>NON‐COMMERCIAL FUNDING</b>: yes </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b> no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> Full paper </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> "" To clarify whether LADA benefit from rosiglitazone" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No evidence the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Zhou 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> equal ratio assumed (not stated in manuscript) </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: yes </p> <p><b>PATIENT CONSENT OBTAINED:</b> yes </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = no </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: No </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Insulin group 42% F(5/12), 58% M 7/12, Insulin plus rosiglitazone 45% F (5/11), 55% M (6/11) </p> <p><b>AGE (mean years (SD))</b>: Insulin group 51.8 (13.5), Insulin plus rosiglitazone 46.5 (12.2). </p> <p><b>ETHNIC GROUPS (%)</b>: not stated </p> <p><b>DURATION OF DISEASE (median years (min‐max))</b>: Insulin = 0.8 (0.3‐4.0), Insulin + rosiglitazone =1.8 (0.1‐5.0) </p> <p><b>INCLUSION CRITERIA</b>: (1) diabetes diagnosed according to the report of WHO 1999 (2) age at onset over 25 years old (3) no ketosis within the first six months of diagnosis (4) disease duration less than five years (5) GAD‐Ab positive testing twice within one month (6) FCP level of 0.3nmol/L or more. </p> <p><b>EXCLUSION CRITERIA</b>: impaired liver, kidney or heart function or other severe diseases. </p> <p><b>DIAGNOSTIC CRITERIA</b>: diabetes according to the report of WHO 1999 with GAD‐Ab positive twice within one month </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Insulin 12, Insulin + rosiglitazone 11 </p> <p><b>LOSS TO FOLLOW‐UP</b>: 14/22 follow‐up to 18 months or 36% lost to follow‐up. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:not reported </p> <p><b>COUNTRY/ LOCATION</b>: China </p> <p><b>SETTING</b>: out‐patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: Insulin + rosiglitazone. Premixed human insulin (Novolin 30 R or Humulin 70/30) was injected twice a day. Rosiglitazone 4 mg/day. Diet advice </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: Insulin. Premixed human insulin (Novolin 30 R or Humulin 70/30) was injected twice a day. Diet advice </p> <p><b>TREATMENT BEFORE STUDY</b>:None </p> <p><b>TITRATION PERIOD</b>: None. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>:Not stated but objectives states "we hypothesized that thiazolidinediones combined with insulin in LADA may have and additional benefit on islet beta cell function" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>Collected at baseline, 6 12 and 18 months. <br> 1. Fasting C‐peptide (nmol/L), 2. Insulin dose (U/day), 3. HbA1c (%), 4. Fasting C‐peptide (nmol/L), 5. C‐peptide after 2h 75‐g glucose load (nmol/L). </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 18 months </p> <p><b>DURATION OF FOLLOW‐UP</b>: 18 months. All 23 patients followed‐up for 6 months, but only 17 for 12 months and 14 for 18 month </p> <p><b>RUN‐IN PERIOD</b>: None </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: yes </p> <p><b>NON‐COMMERCIAL FUNDING:</b> yes </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b> no </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> "we hypothesized that LADA patients might benefit from thiazolidinediones treatment" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No evidence the analyst was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ITT not described, no description of dealing with missing data</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Funded by grant from Glaxo‐SmithKline Investment Co.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Zhu 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT):</b> yes, parallel RCT </p> <p><b>RANDOMISATION RATIO:</b> equal ratio assumed (not stated in manuscript) </p> <p><b>NON‐INFERIORITY DESIGN:</b> no </p> <p><b>EQUIVALENCE DESIGN:</b> no </p> <p><b>ETHICS APPROVAL OBTAINED</b>: unknown </p> <p><b>PATIENT CONSENT OBTAINED:</b> unknown </p> <p><b>BLINDING OF PATIENT (P), EDUCATOR (E), RESEARCHER (R):</b> P = no, E = no, R = no </p> <p><b>ANALYSIS BY INTENTION TO TREAT</b>: No </p> <p><b>POWER CALCULATION</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>WHO PARTCIPATED</b>: </p> <p><b>SEX (female% / male%)</b>: Insulin group 45% F(15/33), 54% M 18/33, Insulin + Chinese medicine 51% F (16/31), 49% M (15/31), SU group 45% F (9/20), 55% M (11/20). </p> <p><b>AGE (mean years (SD))</b>: Insulin group (39.8), Insulin+ Chinese medicine (40.5), SU group (41.6) </p> <p><b>ETHNIC GROUPS (%)</b>: not stated </p> <p><b>DURATION OF DISEASE (mean months (SD))</b>: Insulin 20.3 (3.6), Insulin + Chinese medicine 19.5 (3.9), SU group 19.8 (4.3) </p> <p><b>INCLUSION CRITERIA</b>: (1) Adult (32 years +) (2) type 2 diabetes with GADA+ and ICA + . </p> <p><b>EXCLUSION CRITERIA</b>: none given </p> <p><b>DIAGNOSTIC CRITERIA</b>: type 2 diabetes with GADA+ and ICA+ </p> <p><b>CO‐MORBIDITIES</b>:Not given </p> <p><b>CO‐MEDICATIONS</b>: Not given </p> <p><b>NUMBER:</b> Insulin 33, IInsulin+ Chinese medicine 31, SU 20. </p> <p><b>LOSS TO FOLLOW‐UP</b>: 0% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>NUMBER OF STUDY CENTRES</b>:2 </p> <p><b>COUNTRY/ LOCATION</b>: China </p> <p><b>SETTING</b>: out‐patient </p> <p><b>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: Insulin or insulin plus Chinese medicine </p> <p><b>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY)</b>: Sulphonylurea </p> <p><b>TREATMENT BEFORE STUDY</b>:None </p> <p><b>TITRATION PERIOD</b>: None </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>:Not stated but abstract states "to study the effect of integrated Chinese and Westerm medicine on improvement of islet beta cell function in treating patients with latent autoimmune diabetes in adults (LADA)" </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>:Not stated </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>1.HbA1c, 2. FBG, 3. Stimulated C‐peptide and changes in C‐peptide</p> <p><b>PRIMARY OUTCOME(S) (as stated in the publication)</b>: </p> <p><b>SECONDARY OUTCOMES (as stated in the publication)</b>: </p> <p><b>ADDITIONAL OUTCOMES</b>: </p> <p>1. HbA1c (%), 2. Fasting C‐peptide (nmol/L)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>DURATION OF INTERVENTION</b>: 12 months </p> <p><b>DURATION OF FOLLOW‐UP</b>: 12 months </p> <p><b>RUN‐IN PERIOD</b>: None </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>:Chinese </p> <p><b>COMMERCIAL FUNDING</b>: no </p> <p><b>NON‐COMMERCIAL FUNDING:</b> yes </p> <p><b>PUBLICATION STATUS (PEER REVIEW JOURNAL):</b> yes </p> <p><b>PUBLICATION STATUS (JOURNAL SUPPLEMENT):</b> yes </p> <p><b>PUBLICATION STATUS (ABSTRACT):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote</b> " To study the effect of integrated Chinese and Westerm medicine on improvement of the islet beta cell function in treating patients with latent autoimmune diabetes mellitus in adults (LADA)" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unblinded but not indication the analysis was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No problems identified</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CG: control group; IG = intervention group</p> </div> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD006165-sec2-0021"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006165-sec2-0020" class="jump-to">included studies</a></li> <li><a href="#CD006165-sec2-0022" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0015">Alvarsson 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 2 diabetes. Antibody positive patients were excluded.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0016">Berkis 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Administration of rhGAD65 for specific autoimmune response. No clinical intervention.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0017">Bjork 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes. Patients were insulin dependent at diagnosis.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0018">Chaillous 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes. Mainly children.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0019">Conget 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes. Insulin dependent at diagnosis, due to hyperglycaemia, ketosis or diabetic ketoacidosis. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0020">DCCT Group 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0021">Desai 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>LADA but not an intervention study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0022">Desai 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>LADA but not an intervention study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0023">E‐Longmire 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Numbers of antibody positive patients treated or followed‐up could not be identified. Contact with authors unsuccessful. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0024">Goday 1993</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0025">Heise 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0026">Karges 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes. Case study.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0027">Kobayashi 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Republication of findings in <a href="references#CD006165-bbs2-0005">Kobayashi 1996</a> and <a href="references#CD006165-bbs2-0008">Maruyama 2003</a>. No new findings. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0028">Leslie 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No intervention. Review.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0029">Leslie 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No intervention. Review</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0030">Linn 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0031">Littorin 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No intervention. Observational study.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0032">Loriz Peralta 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Observational study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0033">Martin 1991</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0034">Matsumoto 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Case study.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0035">Mattews 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 2 diabetes with no antibodies tested.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0036">Mayorov A 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 2 diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0037">Murao 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>LADA but not an intervention study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0038">Ovalle 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 2 diabetes. No antibodies tested.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0039">Pozzilli 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0040">Pozzilli 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0041">Pugliese 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. No intervention.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0042">Ravnik‐Oblak 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 2 diabetes. No antibodies tested.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0043">Raz 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 diabetes (ketones)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0044">Rosario 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>LADA. Observational.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0045">Sa 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Before and after study with no control arm.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0046">Schloot 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 in adults and paediatrics</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0047">Schories 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0048">Scranton 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>LADA but no mention of antibody positivity in the selection criteria.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0049">Secchi 1990</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0050">Steffes 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes. No intervention.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0051">Stenstrom 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Review, not a primary study.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0052">Takino 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not an intervention study. Commentary only.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0053">Turner 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No intervention.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0054">van Deutekom 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>LADA systematic review</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0055">Vidal 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not LADA. Type 1 (classical) diabetes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0056">Weng 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 2 diabetes with no autoantibody testing</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006165-bbs2-0057">Zinman 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not an intervention study. Observational study results.</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>LADA: latent autoimmune diabetes in adults</p> </div> </div> </p> </section> <section class="characteristicsOfOngoingStudies" lang=""> <div class="section-header" id="CD006165-sec2-0022"> <h3 class="title">Characteristics of ongoing studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006165-sec2-0020" class="jump-to">included studies</a></li> <li><a href="#CD006165-sec2-0021" class="jump-to">excluded studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Agardh 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised Controlled Trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Male and female patients between 30‐70 years of age, presence of GAD65 antibodies, detectable C‐peptide level, patients requiring treatment with diet and/or oral hypoglycaemic agents (OHA), </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>rhGAD65 formulated in Alhydrogel® (Diamyd®) compared to placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, C‐peptide, blood glucose and insulin requirement</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>December 2004</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Carl‐David Agardh. University Hospital MAS, Malmo, Sweden</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Brophy 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised, controlled, parallel‐group study to investigate the clinical effectiveness of early insulin treatment in patients with LADA </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised Controlled Trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>GAD positive (101+ WHO Units) Type 2 within 12 months of diagnosis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin or standard care (diet, followed by metformin, followed by glitazone with or without metformin, followed by insulin) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, FCP, Weight, GAD antibody, HOMA, Quality of life, blood pressure/total cholesterol. <br> Adverse events </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2007</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Brophy S, School of Medicine, Swansea University. <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="7f0c511d0d100f17063f0c081e110c1a1e511e1c510a14">[email&#160;protected]</a></p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>This trial has been officially terminated early (before the specified date for its conclusion in the protocol) due to the low recruitment rate of participants. </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Buzzetti 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Non Insulin Requiring Autoimmune Diabetes (NIRAD) project</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>GAD or IA‐2 positive T2DM already on treatment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin or metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>beta cell failure using stimulated C‐peptide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2006</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Raffaella Buzzetti, Dept. of Endocrinology and Diabetes <br> University Campus Bio‐Medico <br> Via E. Longoni, 83 <br> Rome 00155 <br> Italy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Grill 2010 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Is "Beta Cell Rest" by Insulin Treatment Beneficial Compared to State‐of‐the Art Enhancers of Insulin Secretion in Preserving Beta Cell Function in Subjects With Latent Autoimmune Diabetes of the Adult (LADA)? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Diabetes diagnosed during 0‐3 years before entering the study, age &gt; or equal to 30 years &lt; or equal to 75 years, anti‐GAD positivity, fasting C‐peptide &gt; or equal to 0,3 ng/ml, no need for insulin treatment by clinical judgement for at least 3 months following the diagnosis of diabetes, HbA1c &gt; 15 % above the upper limit of normal. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Metformin + NPH insulin compared to metformin + sitagliptin +/‐ repaglinide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fasting and glucagon‐stimulated C‐peptide, HbA1c</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>March 2009</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Valdemar Grill Te: 47 72825188 email:<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="89ffe8e5edece4e8fba7eefbe0e5e5c9e7fde7fca7e7e6">[email&#160;protected]</a></p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Palmer 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosiglitazone intervention study on patients with type 1.5 diabetes</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Antibody positive T2 diabetes, aged 35 to 69 years, no history of ketonuria.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosiglitazone or glyburide (SU)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fasting and stimulated C peptide, Antibody levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2000</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Jerry Palmer, Seattle Institute for Biomedical and Clinical Research, University of Washington. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Palmer 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Diabetes according to WHO criteria, duration 2 month to 5 years, diabetes controlled by diet and insulin for 2 or more weeks, aged 30 to 65, positive for GAD autoantibodies, fasting C‐peptide of 0.3 nmol/L or greater at screening </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DiaPep277 compared to placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Undefined</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>October 2002</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Jerry P Palmer University of Washington.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Zhou 2010 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Protective Effects of Sitagliptin on β Cell Function in Patients With Adult‐onset Latent Autoimmune Diabetes(LADA) (DPP‐ⅣLADA) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomized controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Age 25‐70, Diabetes diagnosed according to the report of WHO in 1999, disease duration of less than 3 year, no ketoacidosis within the first 6 months after diagnosis of diabetes, GADA positive twice within one month, FCP level of 0.2 nmol/L or more. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sitagliptin combined with insulin therapy compared to sitagliptin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HOMA‐IR, Intravenous glucose tolerance test (assessment of beta cell function)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>May 2010</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Zhiguang Zhou, Diabetes Center, Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, China </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD006165-sec1-0011"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD006165-tbl-0002"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">HbA1c mean difference in insulin compared to tablet</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Average mean difference in HbA1c from baseline to endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>160</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.26 [‐2.39, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006165-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-CMP-001-01.png?filename=nCD006165-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20HbA1c%20mean%20difference%20in%20insulin%20compared%20to%20tablet%2C%20Outcome%201%20Average%20mean%20difference%20in%20HbA1c%20from%20baseline%20to%20endpoint.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD006165-fig-00101" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-001-01.png" alt="Comparison 1 HbA1c mean difference in insulin compared to tablet, Outcome 1 Average mean difference in HbA1c from baseline to endpoint."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 HbA1c mean difference in insulin compared to tablet, Outcome 1 Average mean difference in HbA1c from baseline to endpoint. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Mean difference of HbA1c at study end point <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>160</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.24 [‐2.49, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006165-fig-00102"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-CMP-001-02.png?filename=nCD006165-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20HbA1c%20mean%20difference%20in%20insulin%20compared%20to%20tablet%2C%20Outcome%202%20Mean%20difference%20of%20HbA1c%20at%20study%20end%20point.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.2</div> </div> <hr class="top"><img data-id="CD006165-fig-00102" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-001-02.png" alt="Comparison 1 HbA1c mean difference in insulin compared to tablet, Outcome 2 Mean difference of HbA1c at study end point."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 HbA1c mean difference in insulin compared to tablet, Outcome 2 Mean difference of HbA1c at study end point. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006165-tbl-0003"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Sensitivity analysis</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 HbA1c at final point <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>313</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.11 [‐2.04, ‐0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006165-fig-00201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-CMP-002-01.png?filename=nCD006165-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Sensitivity%20analysis%2C%20Outcome%201%20HbA1c%20at%20final%20point.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.1</div> </div> <hr class="top"><img data-id="CD006165-fig-00201" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-002-01.png" alt="Comparison 2 Sensitivity analysis, Outcome 1 HbA1c at final point."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis, Outcome 1 HbA1c at final point.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Mean difference from baseline at study endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>313</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.96 [‐1.90, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006165-fig-00202"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-CMP-002-02.png?filename=nCD006165-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Sensitivity%20analysis%2C%20Outcome%202%20Mean%20difference%20from%20baseline%20at%20study%20endpoint.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.2</div> </div> <hr class="top"><img data-id="CD006165-fig-00202" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-002-02.png" alt="Comparison 2 Sensitivity analysis, Outcome 2 Mean difference from baseline at study endpoint."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis, Outcome 2 Mean difference from baseline at study endpoint. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD006165-fig-0001"> <img data-id="CD006165-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-AFig-FIG01.png" alt="Study flow diagram."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-AFig-FIG01.png?filename=nCD006165-AFig-FIG01.ppt&amp;title=1&amp;caption=Study%20flow%20diagram.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006165-fig-0002"><img data-id="CD006165-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-AFig-FIG02.png" alt="Forest plot of comparison: Insulin compared to tablet , Outcome: Average mean difference in HbA1c from baseline to study endpoint."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Forest plot of comparison: Insulin compared to tablet , Outcome: Average mean difference in HbA1c from baseline to study endpoint. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-fig-0002" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-AFig-FIG02.png?filename=nCD006165-AFig-FIG02.ppt&amp;title=2&amp;caption=Forest%20plot%20of%20comparison%3A%20Insulin%20compared%20to%20tablet%20%2C%20Outcome%3A%20Average%20mean%20difference%20in%20HbA1c%20from%20baseline%20to%20study%20endpoint.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-AFig-FIG02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006165-fig-0003"><img data-id="CD006165-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-AFig-FIG03.png" alt="Forest plot of comparison: 2 Sensitivity analysis, outcome: 2.1 HbA1c at final point."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Sensitivity analysis, outcome: 2.1 HbA1c at final point.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-fig-0003" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-AFig-FIG03.png?filename=nCD006165-AFig-FIG03.ppt&amp;title=3&amp;caption=Forest%20plot%20of%20comparison%3A%202%20Sensitivity%20analysis%2C%20outcome%3A%202.1%20HbA1c%20at%20final%20point.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-AFig-FIG03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006165-fig-0004"><img data-id="CD006165-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-AFig-FIG04.png" alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-fig-0004" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-AFig-FIG04.png?filename=nCD006165-AFig-FIG04.ppt&amp;title=4&amp;caption=Methodological%20quality%20summary%3A%20review%20authors%27%20judgements%20about%20each%20methodological%20quality%20item%20for%20each%20included%20study.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-AFig-FIG04.png">Open in new tab</a></div> </div> <div class="figure" id="CD006165-fig-0005"><img data-id="CD006165-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-AFig-FIG05.png" alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-fig-0005" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-AFig-FIG05.png?filename=nCD006165-AFig-FIG05.ppt&amp;title=5&amp;caption=Methodological%20quality%20graph%3A%20review%20authors%27%20judgements%20about%20each%20methodological%20quality%20item%20presented%20as%20percentages%20across%20all%20included%20studies.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-AFig-FIG05.png">Open in new tab</a></div> </div> <div class="figure" id="CD006165-fig-00101"><img data-id="CD006165-fig-00101" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-001-01.png" alt="Comparison 1 HbA1c mean difference in insulin compared to tablet, Outcome 1 Average mean difference in HbA1c from baseline to endpoint."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 HbA1c mean difference in insulin compared to tablet, Outcome 1 Average mean difference in HbA1c from baseline to endpoint. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/references#CD006165-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-CMP-001-01.png?filename=nCD006165-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20HbA1c%20mean%20difference%20in%20insulin%20compared%20to%20tablet%2C%20Outcome%201%20Average%20mean%20difference%20in%20HbA1c%20from%20baseline%20to%20endpoint.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006165-fig-00102"><img data-id="CD006165-fig-00102" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-001-02.png" alt="Comparison 1 HbA1c mean difference in insulin compared to tablet, Outcome 2 Mean difference of HbA1c at study end point."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 HbA1c mean difference in insulin compared to tablet, Outcome 2 Mean difference of HbA1c at study end point. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/references#CD006165-fig-00102" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-CMP-001-02.png?filename=nCD006165-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20HbA1c%20mean%20difference%20in%20insulin%20compared%20to%20tablet%2C%20Outcome%202%20Mean%20difference%20of%20HbA1c%20at%20study%20end%20point.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-001-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006165-fig-00201"><img data-id="CD006165-fig-00201" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-002-01.png" alt="Comparison 2 Sensitivity analysis, Outcome 1 HbA1c at final point."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis, Outcome 1 HbA1c at final point.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/references#CD006165-fig-00201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-CMP-002-01.png?filename=nCD006165-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Sensitivity%20analysis%2C%20Outcome%201%20HbA1c%20at%20final%20point.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-002-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006165-fig-00202"><img data-id="CD006165-fig-00202" src="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-002-02.png" alt="Comparison 2 Sensitivity analysis, Outcome 2 Mean difference from baseline at study endpoint."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis, Outcome 2 Mean difference from baseline at study endpoint. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/references#CD006165-fig-00202" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/ppt/CDSR/CD006165/image_n/nCD006165-CMP-002-02.png?filename=nCD006165-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Sensitivity%20analysis%2C%20Outcome%202%20Mean%20difference%20from%20baseline%20at%20study%20endpoint.&amp;citation=Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, 9. Art. No.: CD006165. DOI: http://dx.doi.org/10.1002/14651858.CD006165.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006165.pub3/media/CDSR/CD006165/image_n/nCD006165-CMP-002-02.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD006165-tbl-0001" class="summary-of-findings framed"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Insulin compared with sulphonylurea compounds for latent autoimmune diabetes (LADA) in adults</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients with LADA </p> <p><b>Settings:</b> Out‐patients </p> <p><b>Intervention:</b> Insulin </p> <p><b>Comparison:</b> Oral antidiabetic drugs (sulphonylureas) </p> </td> </tr> <tr class="table-header separated"> <td align="center" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="center" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="center" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect <br> (95% CI)</b> </p> </td> <td align="center" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of Participants <br> (studies)</b> </p> </td> <td align="center" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence <br> (GRADE)</b> </p> </td> <td align="center" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="center" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Sulphonylureas</b> </p> </td> <td align="center" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin</b> </p> </td> </tr> <tr class="separated"> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Development of diabetic complications</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="center" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> <p>Follow‐up:</p> <p>12+ months</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(5 studies)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Only 5 studies reported data.</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health‐related quality of life</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Death from any cause</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health service utilisation and costs</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HbA1c at study endpoint</b> </p> <p>Follow‐up:</p> <p>12+ months</p> </td> <td align="center" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean HbA1c ranged across control groups from <br> 7.3% to 11.2% </p> </td> <td align="center" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c in the intervention group was <br> 1.3% lower (2.4% lower to 0.1 lower); </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>160 <br> (4 studies) </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝ <br> <b>low</b><sup>1</sup> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence <br> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> considerable heterogeneity </p> <p>HbA1c: glycosylated haemoglobin A1c</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006165-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Overview of study populations</span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Study ID</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention(s) &amp; control(s)</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] screened</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] randomised</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] adverse events</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] ITT</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] finishing study</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[%] of randomised participants <br> finishing study</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0003">Cabrera‐Rode 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin + SU</p> <p>C1: Insulin</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 6</p> <p>C1: 8</p> <p>T: 14</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 6</p> <p>C1: 8</p> <p>T: 14</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 6</p> <p>C1: 8</p> <p>T: 14</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 100%</p> <p>C1: 100%</p> <p>T: 100%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0004">Davis 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin (in patients with FBG &gt; 14.9 mmol/L)</p> <p>C1: SU (in patients with a FBG &gt; 14.9 mmol/L)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: 5102 (all patients type 2 and LADA)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: 164</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 65</p> <p>C1: 88</p> <p>T: 153</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: 93%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0004">Davis 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin (in patients with FBG &lt; 15 mmol/L)</p> <p>I2: SU (in patients with FBG &lt; 15 mmol/L)</p> <p>C1: Conventional (in patients with FBG &lt;15 mmol/L)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>I2: ‐</p> <p>C1: ‐</p> <p>T: 5102 (all patients type 2 and LADA)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>I2: ‐</p> <p>C1: ‐</p> <p>T: 362</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>I2: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>I2: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 95</p> <p>I2: 140</p> <p>C1: 100</p> <p>T: 335</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>I2: ‐</p> <p>C1: ‐</p> <p>T: 93%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0006">L‐Hallin 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: SU + insulin</p> <p>C1:Placebo + insulin</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 3</p> <p>C1: 12</p> <p>T: 15</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 2</p> <p>C1: 11</p> <p>T: 13</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 66%</p> <p>C1: 92%</p> <p>T: 87%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0001">Agardh 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: GAD65 (4 ug)</p> <p>I2: GAD65 (20 ug)</p> <p>I3: GAD65 (100 ug)</p> <p>I4: GAD65 (500 ug)</p> <p>C1: Placebo</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>I2: ‐</p> <p>I3: ‐</p> <p>I4: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 9</p> <p>I2: 8</p> <p>I3: 9</p> <p>I4: 8</p> <p>C1: 13</p> <p>T: 47</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 10</p> <p>I2: 7</p> <p>I3: 9</p> <p>I4: 12</p> <p>C1: 13</p> <p>T: 51</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: n/a</p> <p>I2: n/a</p> <p>I3: n/a</p> <p>I4: n/a</p> <p>C1: n/a</p> <p>T: n/a</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 9</p> <p>I2: 8</p> <p>I3: 9</p> <p>I4: 8</p> <p>C1: 13</p> <p>T: 47</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 100%</p> <p>I2: 100%</p> <p>I3: 100%</p> <p>I4: 100%</p> <p>C1: 100%</p> <p>T: 100%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0002">Agardh 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: GAD65 (4 ug)</p> <p>I2: GAD65(20 ug)</p> <p>I3: GAD65(100 ug)</p> <p>I4: GAD65(500 ug)</p> <p>C1: Placebo</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>I2: ‐</p> <p>I3: ‐</p> <p>I4: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 9</p> <p>I2: 8</p> <p>I3: 9</p> <p>I4: 8</p> <p>C1: 13</p> <p>T: 47</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 0</p> <p>I2: 1 SAE</p> <p>I3: 2 SAE I4: 3 SAE C1: 6 SAE</p> <p>T: 14 SAE</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: PPA</p> <p>I2: PPA</p> <p>I3: PPA</p> <p>I4: PPA</p> <p>C1:PPA</p> <p>T: PPA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 7</p> <p>I2: 7</p> <p>I3: 7</p> <p>I4: 8</p> <p>C1: 11</p> <p>T: 40</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 78%</p> <p>I2: 88%</p> <p>I3: 78%</p> <p>I4: 100%</p> <p>C1: 85%</p> <p>T: 86%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0005">Kobayashi 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin</p> <p>C1: SU</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1:= ‐</p> <p>C1: = ‐</p> <p>T: = ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 5</p> <p>C1:5</p> <p>T: 10</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: n/a</p> <p>C1: n/a</p> <p>T: n/a</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 5</p> <p>C1: 5</p> <p>T: 10</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 100%</p> <p>C1: 100%</p> <p>T: 100%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0008">Maruyama 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin</p> <p>C1: SU</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: 3246</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1:24</p> <p>C1:30</p> <p>T: 54</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: n/a</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: n/a</p> <p>C1:n/a</p> <p>T: n/a</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 24</p> <p>C1:30</p> <p>T: 54</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 100%</p> <p>C1:100%</p> <p>T: 100%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0009">Maruyama 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin</p> <p>C1: SU</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: 4089 (72 eligible, 61 enrolled)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 30</p> <p>C1: 30</p> <p>T: 60</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: 60</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: n/a</p> <p>C1:n/a</p> <p>T: n/a</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 30</p> <p>C1: 30</p> <p>T: 60</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 100%</p> <p>C1: 100%</p> <p>T: 100%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0012">Yang 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin + RSG (GADA &gt; 175 U/ml and FCP &gt; 3 nmol/L)</p> <p>C2: Insulin (GADA &gt; 175 U/ml and FCP &gt; 3 nmol/L)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: 149</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 12</p> <p>C2: 12</p> <p>T: 24</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 3</p> <p>C1: 0</p> <p>T: 3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>T: n/a</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 12</p> <p>C1: 12</p> <p>T: 24</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 100%</p> <p>C1: 100%</p> <p>T: 100%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0012">Yang 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: RSG (GADA &lt; 175 U/ml and FCP &lt; 3 nmol/L)</p> <p>C1: SU (GADA &lt; 175 U/ml and FCP &lt; 3 nmol/L)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: 149</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I2: 15</p> <p>C1:15</p> <p>T: 30</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 0</p> <p>C1: 0</p> <p>T: 0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>T: n/a</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 15</p> <p>C1: 14</p> <p>T: 29</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 100%</p> <p>C1: 93%</p> <p>T: 100%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0013">Zhou 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin + RSG</p> <p>C1: Insulin</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 11</p> <p>C1:12</p> <p>T: 23</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 0</p> <p>C1: 0</p> <p>T: 0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 7</p> <p>C1: 7</p> <p>T: 14</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 64%</p> <p>C1: 58%</p> <p>T: 61%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0014">Zhu 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin + Chinese medicine</p> <p>C1: Insulin</p> <p>C2: SU</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 31</p> <p>C1: 33</p> <p>C2: 20</p> <p>T: 84</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>C2: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: n/a</p> <p>C1: n/a</p> <p>C2: n/a</p> <p>T: n/a</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 31</p> <p>C1: 33</p> <p>C2: 20</p> <p>T: 84</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 100%</p> <p>C1: 100%</p> <p>C2: 100%</p> <p>T: 100%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0007">Li 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin + Vitamin D</p> <p>C1: Insulin</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: n/a</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 17</p> <p>C1: 18</p> <p>T: 35</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 0</p> <p>C1: 0</p> <p>T: 0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: n/a</p> <p>C1:n/a</p> <p>T: n/a</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 17</p> <p>C1: 18</p> <p>T: 35</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 100%</p> <p>C1: 100%</p> <p>T: 100%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0011">Xu 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin + TYK</p> <p>C1: Insulin</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 37</p> <p>C1: 37</p> <p>T: 54</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 37</p> <p>C1: 37</p> <p>T: 74</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 100%</p> <p>C1: 100%</p> <p>T: 100%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD006165-bbs2-0010">Thunander 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: Insulin</p> <p>C1: Diet +/‐ metformin and/or SU</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 20</p> <p>C1: 17</p> <p>T: 37</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 0</p> <p>C1: 0</p> <p>T: 0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: ‐</p> <p>C1: ‐</p> <p>T: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 18</p> <p>C1: 15</p> <p>T: 33</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: 90%</p> <p>C1: 88%</p> <p>T: 89%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>Total</i> </b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>T: 1060</i> </b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>I1: 567</i> </b> </p> <p><b><i>C1: 452</i> </b> </p> <p><b><i>T: 1019</i> </b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>'‐' denotes not reported</p> <p>C: control; FCP: fasting C‐peptide; FBG: fasting blood glucose; GADA: glutamic acid decarboxylase antibodies; I: intervention; ITT: intention‐to‐treat; n/a: not applicable; PPA: per protocol analysis; RSG: rosiglitazone; SAE: serious adverse events; SU: sulphonylurea; T: Total </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Overview of study populations</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/full#CD006165-tbl-0004" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006165-tbl-0002" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">HbA1c mean difference in insulin compared to tablet</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Average mean difference in HbA1c from baseline to endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>160</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.26 [‐2.39, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Mean difference of HbA1c at study end point <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>160</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.24 [‐2.49, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">HbA1c mean difference in insulin compared to tablet</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/references#CD006165-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006165-tbl-0003" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Sensitivity analysis</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 HbA1c at final point <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>313</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.11 [‐2.04, ‐0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Mean difference from baseline at study endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>313</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.96 [‐1.90, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Sensitivity analysis</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006165.pub3/references#CD006165-tbl-0003" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="fr#CD006165-note-1204">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD006165-note-1201">日本語</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="/cochrane-theme/vendor/ie9.js?t=1581423095000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581423095000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717777000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717709000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717714000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006165\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006165\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006165\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006165\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006165\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581423095000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006165.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006165.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD006165.pub3/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD006165.pub3/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006165.pub3%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583239775255" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583239775259" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006165&#x2e;pub3&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD006165.pub3";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 